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ABSTRACT 
 
Shusaku Shibutani: Drosophila E2F1 is degraded during S phase in a PCNA-, Cul4-, and 
Cdt2-dependent manner 
(Under the direction of Robert J. Duronio) 
 
 During the development of multicellular organisms, cell proliferation is tightly 
regulated by intrinsic and extrinsic cues, generating a spatiotemporal cell cycle pattern. For 
instance, cell cycles are very rapid during early embryogenesis, resulting in a sufficient 
number of cells for tissue formation. In contrast, cells that are going to differentiate usually 
arrest the cell cycle in G1 phase and subsequently enter the quiescent state (G0). Failure to 
maintain active cell cycles during early embryogenesis and to arrest the cell cycle before 
differentiation will cause destructive effects on tissue development and homeostasis. Since 
cells usually arrest in G1, an important decision step in the cell cycle is whether the cell stays 
in G1 phase or enters S phase. When G1 cells enter S phase, positive cell cycle regulators 
such as Cyclin E, RnrS, PCNA, and DNA polymerase are coordinately induced by the family 
of the E2F transcription factors.  
 In Drosophila, these genes are regulated by a single E2F (E2F1). During the early 
embryogenesis of Drosophila, E2F1-target genes are expressed ubiquitously, facilitating the 
rapid cell cycles. Later in embryogenesis, E2F1-target genes are downregulated before cells 
arrest in G1. This implies that during embryogenesis developmentally-regulated E2F1 
activity causes this characteristic cell cycle pattern. In this thesis, we show that the initial 
downregulation of E2F1-target genes is preceded by the developmentally-regulated onset of 
 ii
E2F1 destruction. Furthermore, we discovered that DNA replication induces E2F1 
destruction in a PCNA-, Cul4-, and Cdt2-dependent manner. Expression of a stabilized form 
of E2F1 in the larval wing disc caused apoptosis and disrupted adult wing morphology, while 
expression in the larval salivary gland arrested the endocycle, a variant G1-S cell cycle that 
lacks mitosis and results in polyploidy. Taken together, our data suggests the existence of a 
robust negative feedback mechanism where E2F1 induces DNA replication, which in turn 
downregulates E2F1 by proteolysis, and this negative feedback loop is required for normal 
development of Drosophila.  
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CHAPTER I 
INTRODUCTION 
 
Proper control of cell cycles is a fundamental feature of living organisms. For 
example, unicellular organisms respond to the surrounding environment; they actively 
proliferate in a nutrient-rich condition, and arrest the cell cycle when nutrients are limited. In 
the case of yeast, the cell cycle is regulated in response to mating pheromones (Humphrey 
and Pearce, 2005). On the other hand, multicellular organisms have evolved complex 
regulatory mechanisms for the cell cycle in order to form and maintain functional tissue 
morphology. The proliferation of cells in a tissue is orchestrated by various intrinsic and 
extrinsic cues (Lee and Orr-Weaver, 2003). In multicellular organisms, the cell cycle is 
typically rapid during early embryogenesis, resulting in a sufficient number of cells for tissue 
formation. Later in development, it becomes important to arrest the cell cycle before cells 
differentiate. The failure to arrest the cell cycle will lead to tissue deformation and can result 
in cancer development. Thus, understanding the mechanisms of cell cycle regulation in a 
multicellular organism is of particular importance for both the basic biology and medical 
research fields. 
 
The regulation of the G1-to-S transition 
The canonical cell cycle is composed of four phase: G1, S, G2, and M. During S 
phase, DNA synthesis takes place and the whole genome is replicated, resulting in two 
identical sets of genomes in one nucleus. During M phase, the replicated genomes are 
divided into two nuclei, and the subsequent cytoplasmic division results in two daughter cells. 
G1 and G2 phases are defined as gap phases that separate S phase and M phase. In these gap 
phases, proteins required for the subsequent phase are actively synthesized.  Previous studies 
have identified a large number of cell cycle regulators including Cyclin/Cyclin-dependent 
kinase complexes (Cyc/CDK) and E2 factor (E2F) transcription factors. Cyc/CDK 
complexes phosphorylate a plethora of proteins, and this phosphorylation coordinately drives 
the G1-to-S or G2-to-M transitions. Cyclins are destroyed each cell cycle, and because of this 
every cell cycle transition requires the new synthesis of Cyclins, which is achieved by the 
activity of a variety of transcription factors. One such transcription factor is E2F, which, 
together with its heterodimeric partner DP, induces transcription of genes involved in DNA 
synthesis, mitosis, apoptosis, DNA repair, and differentiation (Blais and Dynlacht, 2004; 
Iaquinta and Lees, 2007; Lee and Orr-Weaver, 2003; Stevaux and Dyson, 2002). E2F is 
negatively regulated by pocket protein family members including the retinoblastoma tumor 
suppressor protein (pRB), p107, and p130. To add further complexity, pocket proteins are 
negatively regulated by Cyc/CDK-mediated phosphorylation. Therefore, E2F, pocket 
proteins, and Cyc/CDK form a potential positive feedback loop (Figure 1.1). 
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 Figure 1.1: Regulators of the G1-to-S transition 
The E2F transcription factor, together with its heterodimeric partner DP, induces DNA replication genes such as 
CycE, ribonuclease reductase small subunit (RnrS), proliferating cell nuclear antigen (Pcna), and DNA 
polymerase. Because of this, E2F acts as a strong positive regulator of the G1-to-S transition. E2F is negatively 
regulated by pocket protein family members (represented by RB in this figure). The phosphorylation of pocket 
proteins by Cyc/CDK complexes results in the dissociation of pocket proteins from E2F, allowing the induction 
of E2F-target gene transcription. Note that E2F, RB, and CycE/CDK2 form a potential positive feedback loop 
that promotes S phase entry.  
 
It is thought that this potential positive feedback loop helps G1 cells to commit their 
entry into S phase (Malumbres and Barbacid, 2001; Yao et al., 2008). Once the activities of 
E2F and CycE/CDK2 reach a critical threshold, they synergistically activate one another, 
facilitating the robust entry into S phase. However, the activities of E2F and CycE/CDK2 
must be suppressed both when the cell is in a quiescent state (G0 phase), and when DNA 
replication is initiated (S phase). Indeed, Cyc/CDK is negatively regulated by CDK inhibitors 
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such as p16INK4a and p27Kip1 (Sherr and Roberts, 1999), and by the proteasome-mediated 
destruction of Cyclins (Nakayama and Nakayama, 2006). The negative regulation of 
Cyc/CDK occurs in a timely manner during the cell cycle, and the misregulation of these 
mechanisms often results in ectopic S phase (Chen and Segil, 1999; de Nooij et al., 1996; 
Lane et al., 1996; Lowenheim et al., 1999; Moberg et al., 2001). In addition to Cyc/CDK 
regulation, previous studies have identified mechanisms that negatively regulate E2F activity. 
The negative regulation involves pocket proteins, repressor E2Fs, proteasome-mediated 
destruction, CycA/CDK2-mediated phosphorylation, and transcriptional repression (see 
below for further details).  
 
The regulatory mechanisms of mammalian and Drosophila E2Fs  
In mammals, eight E2F genes have been identified, and can be generally categorized 
into two groups: activator E2Fs (1, 2 and 3a) and repressor E2Fs (3b and 4-8). When 
activator E2Fs are overexpressed in cultured cells, they often induce S phase entry, followed 
by apoptosis (Kowalik et al., 1995; Qin et al., 1994; Shan and Lee, 1994; Wu and Levine, 
1994). Conversely, the triple knockout of E2f1-3 in mouse embryonic fibroblasts completely 
arrests the cells cycle (Wu et al., 2001). 
As mentioned above, the activity of these activator E2Fs must be suppressed when 
the cell is in the quiescent phase (G0 phase), and when DNA replication is initiated (S phase). 
Failure to suppress E2F activity in G0/G1 or S phase may cause ectopic S phase entry or re-
replication, respectively. Indeed, a significant number of studies in mammals have revealed 
several mechanisms that suppress activator E2Fs.  
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First, activator E2Fs are repressed in G0/G1 by the binding of pRB to the C-termini 
of E2Fs. This binding interferes with the transcriptional activity of E2Fs. In addition, E2F-
bound pRB recruits various chromatin regulatory complexes that contribute to the repression 
of transcription (Blais and Dynlacht, 2007; Frolov and Dyson, 2004). A widely-accepted 
mechanism to re-activate pRB-repressed E2Fs is that extracellular signals induce the 
transcription of CycD, which binds to and activates CDK4 and 6. CycD/CDK4 and 
CycD/CDK6 then hyperphosphorylate pRB, which leads to the dissociation of pRB from 
E2F (Frolov and Dyson, 2004). The importance of the pRB-mediated repression is inferred 
by the fact that many types of cancers have mutations in the Rb gene, and that the loss of Rb 
in model animals leads to failure to maintain cell cycle arrest (Jacks et al., 1992; MacPherson 
et al., 2003; Ruiz et al., 2004; Wu et al., 2003). Also, reduction of E2F activity can suppress 
tumor formation due to loss of pRB (Lee et al., 2002; Yamasaki et al., 1998; Ziebold et al., 
2003).  Second, activator E2Fs on gene promoters are replaced by repressor E2Fs during 
G0/G1, which results in the suppression of E2F-responsive promoters (Trimarchi and Lees, 
2002). The third mechanism is the destruction of E2F1 protein via the ubiquitin-proteasome 
pathway in S/G2 phases. In mammals, the Cul1SKP2 ubiquitin ligase complex has been linked 
to the degradation of E2F1. Cul1SKP2 binds to the N-terminus of E2F1, leading to the 
ubiquitination and subsequent destruction of E2F1 (Marti et al., 1999). Other studies showed 
that the C-terminal truncation of E2F1, 2 and 4 stabilized these proteins, and E2F1 was 
protected from ubiquitination and destruction when bound by pRB (Campanero and 
Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996). The fourth mechanism 
involves the phosphorylation of DP by CycA/CDK2 in S phase. DP forms heterodimers with 
E2Fs, and this heterodimerization is required for the binding of E2F/DP to DNA. In S phase, 
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CycA/CDK2 binds to the N-terminus of activator E2Fs and phosphorylates E2F-bound DP, 
leading to the dissociation of E2F/DP from the DNA (Dynlacht et al., 1994; Dynlacht et al., 
1997; Krek et al., 1994; Krek et al., 1995). Lastly, a recent report showed that homo- and 
heterodimers formed by mouse E2F7/8 bind to the promoter of the E2f1 gene and repress the 
transcription of E2f1 in S/G2 (Li et al., 2008). The combinational loss of E2f7 and 8 resulted 
in embryonic lethality with massive apoptosis induction, and the apoptosis was suppressed 
by additional deletion of E2f1, suggesting that the negative regulation of E2F1 by E2F7/8 is 
important for animal development. 
Despite the large body of data that suggests suppression mechanisms of mammalian 
activator E2Fs, the redundancy that exists in mammals among the eight E2Fs, two DPs (DP1 
and 2), and three pocket proteins (pRB, p107, and p130) makes it difficult to interpret the 
results. A more simplified E2F/DP/RB pathway has been characterized in Drosophila, 
providing an excellent model system to investigate the regulatory mechanisms of E2Fs. In 
Drosophila, two E2Fs (E2F1 and 2), one DP, and two pocket proteins (RBF1 and 2) have 
been identified (Lee and Orr-Weaver, 2003). E2F1, the only known activator E2F in 
Drosophila, shares major characteristics with mammalian activator E2Fs. It induces 
transcription of genes involved in DNA synthesis such as Cyclin E, RnrS, Pcna, and DNA 
polymerase alpha (Dimova et al., 2003; Duronio and O'Farrell, 1994), and regulates 
expression of pro-apoptotic genes such as reaper (Asano et al., 1996), hid, and Dcp-1 (Moon 
et al., 2005). Mutation of E2f1 is lethal and causes inhibition of S phase during 
embryogenesis (Duronio et al., 1995), and overexpression of Drosophila E2F1 can induce 
ectopic S phase entry and apoptosis (Asano et al., 1996; Du et al., 1996b; Duronio et al., 
1996), supporting the idea that Drosophila E2F1 is a positive regulator of the G1-to-S 
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transition and apoptosis. Furthermore, the mechanisms to suppress activator E2Fs are 
conserved between mammals and Drosophila to some extent. Like mammalian activator 
E2Fs, Drosophila E2F1 is suppressed by RBF1-binding (Du et al., 1996a; Xin et al., 2002), 
and suppression of E2F1-target genes by E2F2 has been suggested (Frolov et al., 2001; Weng 
et al., 2003). The ubiquitin-mediated proteolysis of Drosophila E2F1 also exists and was 
previously linked to the Cul1Slmb ubiquitin ligase (Heriche et al., 2003). Although orthologs 
of E2F7/8 do not seem to exist in Drosophila, it has been reported that increased CDK 
activity represses the transcription of the Drosophila E2f1 gene (Reis and Edgar, 2004). 
Unlike mammalian activator E2Fs, no known Cyclin-binding site has been found in 
Drosophila E2F1, and the dissociation of E2F1/DP from the DNA triggered by DP 
phosphorylation has not been reported in Drosophila. 
Despite the simpler E2F/DP/RB pathway in Drosophila, the existence of the 
multiple layers of the E2F suppression mechanisms raises the question: What is the 
biological importance of each mechanism in regulating the suppression of E2F1 activity? A 
previous study has shown that an E2f1 point mutant named E2f1su89, which cannot bind to 
RBF1, is homozygously viable and fertile with no gross developmental defect (Weng et al., 
2003), suggesting that the suppression of E2F1 by RBF1-binding is not required for normal 
development of Drosophila. Likewise, E2f2 null mutant flies are viable with reduced fertility 
in females (Cayirlioglu et al., 2001; Frolov et al., 2001), suggesting that the suppression of 
E2F1 mediated by E2F2 is not essential during development. In addition, microarray data 
using RNAi-treated Drosophila S2 cells and Rbf2 mutant embryos shows that E2F2 and its 
binding partner RBF2 normally regulates cell cycle-independent, differentiation-related 
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genes, which form a different gene cluster than E2F1-regulated, cell cycle-related genes 
(Dimova et al., 2003; Stevaux et al., 2005). 
One possible mechanism that can compensate for the loss of RBF1- or E2F2-
mediated E2F1 suppression is the ubiquitin-mediated destruction of E2F1. Previous studies 
showed that E2F1 is degraded during S phase in the eye disc (Asano et al., 1996) and wing 
disc (Heriche et al., 2003; Reis and Edgar, 2004). Previously, Heriche et al. linked the 
destruction of Drosophila E2F1 to the Cul1Slmb ubiquitin ligase (Heriche et al., 2003). They 
observed slight stabilization of E2F1 in wing discs overexpressing mouse Cul1, which may 
act as a dominant negative Cul1 in Drosophila, and in wing discs of a slmb mutant. However, 
the stabilization of E2F1 during S phase by mouse Cul1 overexpression and slmb mutation 
was incomplete (e.g. only 3% of S phase cells were E2F1 positive in mouse Cul1-
overexpressing wing discs) (Heriche et al., 2003), suggesting the possibility that the S phase-
dependent destruction of Drosophila E2F1 is also mediated by other mechanisms. 
 
 
Drosophila embryos as an experimental model for studying E2F1 regulation 
 
To investigate the regulatory mechanisms of Drosophila E2F1, we started with 
utilizing embryos as an experimental system. The Drosophila embryo provides an excellent 
model system to study the mechanism of E2F1 regulation in a developmental context. The 
cell cycle and the expression pattern of E2F1-target genes have been well-characterized in 
Drosophila embryogenesis (Lee and Orr-Weaver, 2003). In addition, we can take advantage 
of mutant fly resources and genetic tools, with which we can manipulate many aspects of the 
cell cycle in vivo. 
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The first 13 cycles of Drosophila embryogenesis are synchronous, rapid S-M cycles 
that lack obvious gap phases (Figure 1.2). These cycles are driven by maternal supplies of 
mRNAs and proteins (Foe and Alberts, 1983). After the S phase of cycle 14, the first gap 
phase G214 appears. It has been shown that G214 is caused by the degradation of maternal 
string (stg) mRNA and protein (Edgar and Datar, 1996). Stg is a Drosophila ortholog of 
Cdc25 phosphatase that activates CDK1 by removing the inhibitory phosphates. Stg is 
required for the G2-to-M transition, so that the degradation of maternal stg causes G214 
introduction (Edgar and O'Farrell, 1989; Sigrist and Lehner, 1997). After gastrulation begins, 
the developmentally-regulated transcription of zygotic stg regulates the entry into mitosis 
during cycles 14, 15 and 16 (Edgar et al., 1994; Edgar and O'Farrell, 1990).  After cycle 16, 
the first G1 phase appears in the epidermal cells of the embryo (G117), whereas the cells in 
the central nervous system (CNS) continue the S-G2-M cycle, and the cells in the midgut 
enter a G1-S cycle called the endocycle (also referred to as endoreduplication). The initiation 
of G1 phase is achieved by the developmentally-regulated transcription of dacapo (dap), 
which encodes the single Drosophila p27-like CDK inhibitor (de Nooij et al., 1996; Lane et 
al., 1996). Dap induces G117 because it specifically inhibits CycE/CDK2, which is required 
for entry into S phase. The G117-arrested epidermal cells remain in G1 for the rest of 
embryogenesis, and this maintenance of G117 requires the function of RBF1 (Du et al., 
1996a). In Rbf1 mutant embryos, the epidermal cells still initiate G117 due to the 
developmentally-regulated expression of Dap. However, some Rbf1 mutant epidermal cells 
fail to maintain G117 and enter ectopic S phase due to the high activity of E2F1 (Du and 
Dyson, 1999).   
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 Figure 1.2: Drosophila embryonic cell cycles and E2F1-target gene expression 
In the embryo, the first 13 cell cycles are rapid S-M cycles which occur in a common cytoplasm (syncytial 
divisions). These 13 cycles are regulated by maternal supplies of mRNA and protein. At cycle 14, degradation 
of maternal stg mRNA and Stg protein results in the introduction of G2.  Cycles 14-16 (post-blastoderm 
divisions) are S-G2-M cell cycles controlled by the developmentally-regulated expression of Stg. At cycle 17, 
the first G1 appears in the epidermis (G117) due to the inhibition of CycE/CDK2 by the developmentally-
regulated expression of Dap.  The epidermal cells remain arrested in G117 for the rest of embryogenesis, 
whereas the cells in the CNS continue S-G2-M cycles and the cells in the midgut enter G-S cycles (endocycles). 
 
Interestingly, it has been shown that these embryonic cell cycles correlate well with 
the expression pattern of E2F1-target genes such as RnrS, Pcna, DNA polymerase, and CycE 
(Figure 1.2). In the Drosophila embryo, these genes are specifically expressed in cells that 
are actively cycling. Conversely, the expression of these genes is suppressed in cells arrested 
in G1 (e.g. the epidermal cells in G117). However, the collection of mechanisms underlying 
this correlation remains incompletely understood.  
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Dissertation goals 
In this thesis, I will describe the work that I performed with my collaborators 
addressing the regulation of E2F1 activity during Drosophila development. In Chapter II, we 
show that the initial downregulation of E2F1-target gene expression during embryogenesis 
does not require Rbf1 or dap, both of which are inhibitory for the E2F1-CycE positive 
feedback loop. Instead, we propose that the developmentally-regulated onset of E2F1 
destruction may be the mechanism regulating the initial downregulation of E2F1-target genes. 
In addition, we show that E2F1 destruction is strictly dependent on S phase. In Chapter III, 
we focus on the mechanism of S phase-dependent destruction of E2F1. We show that the 
destruction of E2F1 is mediated by PCNA, Cul4, and Cdt2 in a similar manner to the 
destruction of Cdt1, a protein of the pre-replication complex. Interestingly, the stabilization 
of E2F1 during S phase caused apoptosis in mitotically cycling cells in the wing disc, 
whereas it caused cell cycle arrest in endocycling cells in the larval salivary gland. In Chapter 
IV, we describe the finding of a genomic locus that is required for the early zygotic 
expression of RnrS.  This implies that at this stage of development RnrS expression is 
controlled independently of E2F1, which may also explain the initial RBF1-independent 
downregulation of E2F1-target genes during embryogenesis. In Chapter V, these results will 
be discussed in a broad context. 
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CHAPTER II 
 
RBF1-INDEPENDENT TERMINATION OF E2F1-TARGET GENE EXPRESSION 
DURING EARLY DROSOPHILA EMBRYOGENESIS 
 
 
Preface  
 This work was previously published and represents a co-first author effort between 
myself and my collaborator, Lisa Swanhart, a former graduate student in the lab.   
I measured RnrS expression in embryos overexpressing UAS-Rbf1-280 (Figure 2.1A-C), 
dap mutant embryos (Figure 2.2A-D), dap;stg double mutants (Figure 2.9C-E) and dup mutant 
embryos (Figure 2.10).  I analyzed E2f1 protein dynamics throughout embryogenesis (Figure 
2.3 and 2.4B).  I also monitored E2f1 protein levels in a variety of mutant situations (Figure 2.5 
and 2.7A-E). Lisa analyzed the physical interaction between Rbf1 and E2f1 (figure 2.1H) and 
the effects of UAS-Rbf1-280 over-expression during early embryogenesis (Figure 2.1D-G).  
She measured the timing of RnrS decline in wild type embryos (Figure 2.6), RnrS expression 
and E2f1 protein levels in fzr (Figure 2.2E and 2.7F) and Rbf1 mutants (Figure 2.8), and 
monitored Dap protein levels in stg mutants (Figure 2.9A and B) She also analyzed E2f1 
protein dynamics during mitosis (Figure 2.4A).  Both Lisa and I contributed to the writing of 
the manuscript while Robert Duronio conceived the project and finalized the manuscript. 
 
 Shibutani, S., Swanhart, L.M., and Duronio, R.J. (2007). Rbf1-independent  
termination of E2f1-target gene expression during early Drosophila embryogenesis.  
Development 134, 467-78. 
Abstract 
 
The initiation and maintenance of G1 cell cycle arrest is a key feature of animal 
development.  In the Drosophila ectoderm, G1 arrest first appears during the 17th embryonic 
cell cycle.  The initiation of G117 arrest requires the developmentally-induced expression of 
Dacapo, a p27-like Cyclin E/Cdk2 inhibitor.  The maintenance of G117 arrest requires Rbf1-
dependent repression of E2f1-regulated replication factor genes, which are expressed 
continuously during cycles 1-16 when S phase immediately follows mitosis.  The 
mechanisms that trigger Rbf1 repressor function and mediate G117 maintenance are unknown.  
Here we show that the initial down regulation of expression of the E2f1 target gene RnrS, 
which occurs during cycles 15 and 16 prior to entry into G117, does not require Rbf1 or 
p27Dap.  This suggests a mechanism for Rbf1-independent control of E2f1 during early 
development.  We show that E2f1 protein is destroyed in a cell cycle dependent manner 
during S phase of cycles 15 and 16.  E2f1 is destroyed during early S phase, and requires 
ongoing DNA replication.  E2f1 protein re-accumulates in G117 arrested epidermal cells, and 
in these cells the induction of p27Dap activates Rbf1 to repress E2f1 target genes to maintain a 
stable G1 arrest.  
 
Introduction 
Proper control of cell cycle exit is an essential aspect of the development of all multi-
cellular organisms.  Cell cycle exit frequently occurs during G1 phase, and a stable G1 arrest 
is usually necessary for cell differentiation (Myster and Duronio, 2000).  Multiple 
mechanisms contribute to stable G1 quiescence, and these mechanisms can be broadly 
defined as those that initiate the onset of G1 arrest and those that maintain G1 arrest.  
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Disruption of either or both types of regulation can abrogate differentiation, block 
morphogenesis, and contribute to the onset of cancer.  
The initiation of G1 arrest involves the inhibition of G1 Cyclin/Cyclin dependent 
kinase (Cdk) complexes that promote entry into S phase.  These kinases include Cyclin 
D/Cdk4 (CycD/Cdk4) and Cyclin E/Cdk2 (CycE/Cdk2), which are negatively regulated by 
the cyclin dependent kinase inhibitors (CKIs) p16INK4a and p27Kip1, respectively (Sherr and 
Roberts, 1999).  Whereas p16INK4a  acts primarily as a tumor suppressor, the induction of p27 
expression is required for proper cell cycle withdrawal and subsequent differentiation in a 
number of developing mammalian tissues, including the retina, the organ of Corti, and 
skeletal muscle (Chen and Segil, 1999; Chu and Lim, 2000; Levine et al., 2000; Lowenheim 
et al., 1999; Zabludoff et al., 1998).  
The maintenance of G1 arrest occurs through a distinct mechanism involving the 
repression of genes necessary for S phase, which are regulated by the E2F family of 
transcription factors.  E2F activity is controlled mainly through interaction with members of 
the retinoblastoma (pRb) tumor suppressor or “pocket protein” family (DeGregori, 2002; 
Dimova and Dyson, 2005; Trimarchi and Lees, 2002).  During quiescence and early G1, 
hypo-phosphorylated pocket proteins form a complex with E2Fs that recruit co-repressors 
and results in the down-regulation of E2F targets.  In response to growth signals, G1 
Cyclin/Cdk complexes phosphorylate pocket proteins resulting in the dissociation of the 
repressive pocket protein/E2F complex and the induction of transcription of S phase genes.  
In lens cells, trophoblasts, keratinocytes, and neural tissue the maintenance of cell cycle 
arrest is compromised by the loss of pRb, presumably due to an inappropriate increase in E2F 
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activity and the consequent activation of replication genes (Jacks et al., 1992; MacPherson et 
al., 2003; Ruiz et al., 2004; Wu et al., 2003). 
E2F activity can also be regulated independently of pocket proteins.  “E2F” is a 
heterodimer composed of an E2f subunit and a Dp subunit that together are necessary for 
binding DNA (Trimarchi and Lees, 2002).  During S phase, CycA/Cdk2 phosphorylates E2f-
bound Dp resulting in dissociation of the E2f-Dp heterodimer from DNA (Dynlacht et al., 
1994; Dynlacht et al., 1997; Krek et al., 1994; Krek et al., 1995).  Other reports indicate that 
in mammalian cells E2F proteins are destroyed in S/G2 via the ubiquitin-proteasome 
pathway (Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996; 
Marti et al., 1999).  Similarly, E2f1 is destroyed at the G1/S transition in Drosophila 
imaginal disc cells (Asano et al., 1996; Heriche et al., 2003; Reis and Edgar, 2004), and this 
destruction involves the ubiquitin-proteasome pathway (Heriche et al., 2003).  Whether these 
modes of E2F regulation contribute substantially to gene expression and cell cycle control 
during development is not known.  
In a variety of animal species, the cell cycles of early embryonic development display 
several common features.  In general, these cell cycles are very rapid and occur with the 
ubiquitous activity of key regulators such as E2F and CycE/Cdk2.  In some instances (e.g. 
Drosophila and Xenopus) the earliest cell cycles lack measurable gap phases altogether.  As 
development proceeds, different lineages first acquire additional cell cycle controls that result 
in the appearance of gap phases, and then undergo cell cycle exit and differentiation.  The 
mechanisms contributing to specific changes in cell cycle regulation in particular tissue types 
during development remain incompletely understood. 
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Drosophila embryos provide an excellent experimental system to address this issue 
because they execute a stereotyped, developmentally-controlled cell cycle program that is 
well-characterized (Lee and Orr-Weaver, 2003) (Figure 2.1I).  The first 13 cycles are rapid 
S-M cycles driven by ubiquitous maternal factors (Foe and Alberts, 1983).  The first gap 
phase, G2, appears at the blastoderm stage during cell cycle 14 because of degradation of 
maternal string (stg) mRNA and protein (Edgar and Datar, 1996).  stg encodes a Cdc25-type 
phosphatase that removes the inhibitory phosphates from Cdk1 to allow entry into mitosis 
(Edgar and O'Farrell, 1989; Sigrist and Lehner, 1997).  After gastrulation begins, a pulse of 
zygotic transcription of stg in late G2 triggers the entry into mitosis during cycles 14, 15 and 
16 (Edgar et al., 1994; Edgar and O'Farrell, 1990).  In these so-called post-blastoderm 
division cycles there is no G1 phase, and S phase begins immediately after mitosis.  G1 phase 
first appears during cell cycle 17, after which some cells (e.g. in the epidermis) remain 
arrested in G117 while others (e.g. in the midgut) re-enter S phase from G117 and begin 
endoreduplication cycles. 
The regulation of stg establishes a paradigm for developmental control of the 
Drosophila embryonic cell cycle.  The transition from ubiquitous, maternally-provided stg to 
regulated, zygotic expression of stg accounts for both the introduction of the first G2 phase 
and subsequent G2-M cell cycle regulation.  This paradigm also applies to the introduction of 
G1-S regulation in cell cycle 17.  Because Cyclin E is required for S phase in Drosophila 
(Knoblich et al., 1994), the change in activity of CycE/Cdk2 from ubiquitous (cycles 1-16) to 
cell cycle-regulated accounts for both the introduction of G1 phase in cycle 17 and 
subsequent regulation of the G1-S transition (Duronio and O'Farrell, 1995; Richardson et al., 
1993; Sauer et al., 1995).  This transition is achieved in part by zygotic transcription of 
 21
dacapo (dap), which encodes the single Drosophila p27-like CKI (de Nooij et al., 1996; 
Lane et al., 1996).  dap transcription is controlled by a complex cis-acting regulatory region 
that responds to developmental inputs that induce Dap production during cycle 16 (Liu et al., 
2002; Meyer et al., 2002b).  This results in the inhibition of CycE/Cdk2 and the appearance 
of G1 in cycle 17.  Consequently, dap mutant epidermal cells do not enter G117, but instead 
enter S17 immediately after the completion of M16 and undergo an ectopic cell division cycle 
(de Nooij et al., 1996; Lane et al., 1996). 
The maintenance of a stable G117 arrest in the embryonic epidermis requires the 
function of Rbf1, a Drosophila pRb homolog (Du et al., 1996a).   Rbf1 negatively regulates 
the activity of E2f1.  In Drosophila, E2f1 is necessary for the expression of replication factor 
genes including Cyclin E, although these genes are also regulated by additional factors such 
as DREF (Duronio et al., 1998; Duronio et al., 1995; Hirose et al., 1993; Royzman et al., 
1997; Sawado et al., 1998; Yamaguchi et al., 1996).  Rbf1 mutant embryos develop normally 
through cycle 17, and the epidermal cells are able to initiate G117 due to the activity of Dap.  
However, some Rbf1 mutant epidermal cells fail to maintain G1 arrest and ultimately re-enter 
the cell cycle because of inappropriate expression of E2f1 target genes including Cyclin E 
(Du and Dyson, 1999).  The developmental inputs and mechanisms that result in Rbf1 
repressor function and the down-regulation of replication genes are unknown.  Here we show 
that, surprisingly, the initial down regulation of the E2f1 target gene RnrS prior to G117 does 
not require Rbf1 or Dap.  Instead, loss of RnrS expression occurs coincident with the onset of 
S phase-coupled destruction of E2f1 protein, which may provide a mechanism for pRb-
independent regulation of E2F activity. 
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Materials and Methods 
Drosophila strains 
 w1118, prd-Gal4, β tubulin FLP, w ovoD FRT 14A-B/C(1)DX, y f/Y; hsFLP, and 
CycEAR95/CyO were obtained from the Bloomington Stock Center.  UAS dap, dap4454/CyO, 
Df(1)biD3/FM7, dupa1/CyO, dupa3/CyO, arm-Gal4 VP16/TM3 and E2f17172/TM3 have been 
described previously (de Nooij et al., 1996; Duronio et al., 1995; Lane et al., 1996; McEwen 
et al., 2000; Sigrist and Lehner, 1997; Spradling et al., 1995; Whittaker et al., 2000).  y w; 
stg7B/TM3 e as well as UAS Rbf-280/TM3, UAS Rbf1, and Rbf114 FRT14A-B/FM7 were 
kindly provided by Patrick O’Farrell and Wei Du, respectively (Du and Dyson, 1999; Edgar 
and O'Farrell, 1989; Xin et al., 2002).  dap4454/CyO wg-lacZ, Df(1)biD3/FM7Actin-GFP, 
dupa1/CyO wg-lacZ, dupa3/CyO wg-lacZ, CycEAR95/CyO wg-lacZ, and Rbf114 FRT 14A-
B/FM7 Actin-GFP were constructed for this study. Rbf114 germ line clones were generated as 
described (Du and Dyson, 1999).  stg7B dap4454 double mutant embryos were unambiguously 
identified using Dap antibody staining and the altered morphology caused by the stg G214 
arrest phenotype. 
 
RNA in situ hybridization and BrdU labeling 
 Embryos were dechorionated, fixed in a 1:1 mixture of 4% formaldehyde in 
PBS/heptane for 25 minutes, and devitellinized with methanol.  For BrdU labeling, 
dechorionated embryos were permeabilized with octane, pulse-labeled with 1mg/ml BrdU for 
either 5 minutes or 15 minutes in Schneider’s Drosophila medium prior to fixation. Embryos 
were stored in methanol at -20˚C. 
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 In situ hybridization with digoxigenin-labeled antisense RNA probes was performed 
as described (Kearney et al., 2004).  Fluorescent detection of hybrids (FISH) was achieved 
with the TSA Fluorescence System (Perkin Elmer) using a 30 minutes to 1 hour incubation in 
TSA-Cy3 or TSA-Fluorescein.  For all triple fluorescent staining (i.e. FISH anti-protein, anti-
BrdU) except E2f1 or Dap plus FISH, embryos were first processed for FISH, then for 
immuno-detection of proteins, and finally for BrdU detection by acid denaturation of 
chromosomes (Schubiger and Palka, 1987).  For E2f1 or Dap detection plus FISH, the TSA 
Fluorescence System was first used for immuno-detection of E2f1 or Dap, and then the 
embryos were fixed for 30 minutes in 4% formaldehyde to quench the peroxidase prior to 
FISH and BrdU detection. 
 
Immunostaining 
 Embryos were re-hydrated with PBS/0.1% Tween20 (PBS-T) and incubated with 
primary antibodies overnight at 4˚C.  Primary antibodies were: mouse anti-BrdU monoclonal 
antibody (1:100, Becton Dickinson), rabbit anti-E2f1 (1:500 or 1:1000, gift of Maki Asano) 
(Asano et al., 1996), rabbit anti-phospho-tyrosine (1:100, Upstate), rat anti-phospho-tyrosine 
(1:50 or 1:100, R and D Systems), rabbit anti-β galactosidase (1:200, Chemicon), mouse anti-
phospho-Ser10-histone H3 (1:2000, Upstate), rabbit anti-GFP (1:2000, Abcam) and rabbit 
anti-Dap (Lane et al., 1996) (1:600).  Secondary antibodies were: goat anti-mouse Oregon 
Green (1:1000, Molecular Probes), goat anti-mouse-Cy5 (1:500, Jackson), goat anti-mouse-
Cy3 (1:500, Jackson), goat anti-rabbit-Cy2 (1:500, Jackson), goat anti-rabbit rhodamine 
(1:1000, Molecular Probes), donkey anti-rat-Cy5 (1:500, Jackson), and goat anti-rabbit-Cy5 
(1:500, Abcam).  For detection of E2f1 and Dap, the TSA Fluorescence System (Perkin 
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Elmer) was used with a biotin-conjugated anti-rabbit secondary antibody (1:1000, Chemicon).  
Stained embryos were mounted with Fluoromount-G (Southern Biotech) and visualized with 
either a Nikon Eclipse E800 microscope or a Zeiss LSM 510 scanning confocal microscope. 
 
Co-immunoprecipitations and western blotting 
 Immunoprecipitations were performed with extracts from 0-4 hour and 5-8 hour w1118 
embryos as described (Peifer et al., 1993), and analyzed by SDS-PAGE (7.5% pre-cast gel, 
Biorad) and western blotting with mouse anti-Rbf1 (DX-3, 1:4; (Du et al., 1996a)), rabbit 
anti-E2f1 (see above), and mouse anti-Dp (YUN1-3 1:4; (Du et al., 1996b)).  Secondary 
antibodies were ECL™-Sheep anti-mouse HRP (1:5000) and ECL™-Donkey anti-rabbit 
HRP (1:5000) from Amersham Biosciences. 
 
Results 
Phosphorylation controls the activity of Rbf1 in the early embryo   
 The transcripts of E2f1-regulated replication factor genes are present during the first 
16 embryonic cycles even though Rbf1 mRNA and protein are present continuously 
throughout all of early embryogenesis (Keller et al., 2005; Stevaux et al., 2002).  This 
suggests that embryonic Rbf1 activity is regulated post-translationally.  We therefore 
hypothesized that Rbf1 is hyper-phosphorylated and thus inactivated until cycle 16 by 
constitutive G1 Cyclin/Cdk activity, resulting in ubiquitous expression of E2f1 target genes 
(Figure 2.1I).  To test this, we utilized a mutant version of Rbf1 (Rbf-280) containing 
mutations in four Cdk consensus sites that cannot be inhibited by the activity of G1 
Cyclin/Cdk complexes (e.g. CycE/Cdk2) (Xin et al., 2002). UAS Rbf-280 was expressed 
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with two strong drivers that are active during cycles 14-16, prd-Gal4 and arm-Gal4-VP16.  
E2f1 activity was monitored by in situ hybridization with a probe derived from the small 
subunit of ribonucleotide reductase (RnrS), a well-established E2f1 target gene (Duronio et 
al., 1995).  UAS Rbf-280 expression with prd-Gal4 resulted in the precocious termination of 
RnrS expression in alternating segments (Figure 2.1A, C).  Utilizing fluorescent detection of 
RnrS transcripts and BrdU labeling, we confirmed that the precocious termination occurs 
during cycle 15 (Figure 2.1D).  A similar but more widespread result was observed using the 
ubiquitous arm-Gal4-VP16 driver (Figure 2.1E, G).  Little change in RnrS expression was 
observed after expressing wild type Rbf1 (Figure 2.1B, F), indicating that the precocious 
termination of RnrS expression is specific to UAS Rbf-280.  These results suggest that Rbf-
280 can bypass the normal mechanism of Rbf1 control in the early embryo, and are 
consistent with the idea that Rbf1 is hyper-phosphorylated and thus inactivated by 
constitutive Cyclin/Cdk activity in the early embryo to permit expression of replication factor 
genes like RnrS.  
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 Figure 2.1: Rbf1 activity is controlled by phosphorylation in the early embryo.  (A-G) in situ hybridization 
of stage 10 embryos with an RnrS probe.  (A) Sibling control embryo from a collection expressing UAS-Rbf1 
with prd-Gal4.  (B) UAS Rbf1/prd-Gal4.  Arrow marks paired-expressing segment.  (C) UAS Rbf-280/prd-Gal4.  
Arrow denotes the precocious termination of RnrS expression in a paired expressing segment.  (D) UAS Rbf-
280/prd-Gal4 embryo pulse labeled for 15 minutes with BrdU (green). RnrS expression detected by FISH (red).  
Arrow and arrowhead indicate cells in cycle 15 and 16, respectively.  (E) Sibling embryo from a collection 
expressing UAS Rbf-280 with arm-Gal4 VP16.  (F) UAS Rbf1/arm-Gal4 VP16.  (G) UAS Rbf-280/arm-Gal4 
VP16.  (H) Rbf1 was immuno-precipitated from 0-4 and 5-8 hour old w1118 embryo extracts, and the IPs were 
probed for the presence of E2f1 and Dp by western blotting.  (I) Schematic diagrams of the embryonic cell 
cycle program and the regulation of E2f1 activity.  Scale bar is 200 µm. 
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Rbf1 phosphorylation prevents Rbf1 from binding to E2f1 (Du et al., 1996a; Xin et 
al., 2002).  Therefore, our interpretation of the Rbf-280 results predicts that Rbf1/E2f1 
complexes will not be present during early embryogenesis, and that these complexes will be 
detected only after the introduction of G1 control at ~7 hours of development.  Consistent 
with this hypothesis, E2f1 and Rbf1 co-precipitate from 5-8 hour (cycles 16-17) but not 0-4 
hour (prior to cycle 16) embryo extracts  (Figure 2.1H).  Dp co-precipitates with Rbf1 in both 
cases (Figure 2.1H).  The Rbf1/Dp interaction in 0-4 hour old embryos likely represents the 
recently described Myb-MuvB/dREAM complex that contains E2f2/Dp/Rbf and which acts 
to repress many genes involved in developmental processes other than cell cycle progression 
(Korenjak et al., 2004; Lewis et al., 2004).  We have been unable to detect hyper-
phosphorylated Rbf1 by reduced mobility on SDS-PAGE gels, as is commonly performed 
with mammalian pRb.  Nevertheless, our results suggest that in early embryogenesis (cycles 
1-16) Rbf1 is present in a hyper-phosphorylated, inactive form that is not bound to E2f1. 
 
The initial termination of E2f1-target gene expression does not require CycE/Cdk2 
inhibition 
 In wild type embryonic epidermis, the expression of E2f1 targets is terminated prior 
to G117, and Rbf1 is required to maintain repression of E2f1 targets during G117 (Du and 
Dyson, 1999; Duronio and O'Farrell, 1994; Richardson et al., 1993).  Since our data imply 
that Rbf1 is hyper-phosphorylated in the early embryo, we hypothesized that prior to the 
introduction of G117 Rbf1 is converted to a hypo-phosphorylated form that binds E2f1 and 
terminates E2f1 target gene expression.  A possible mechanism for the conversion of Rbf1 to 
a hypo-phosphorylated form is the inhibition of G1 Cyclin/Cdk complexes, specifically 
 28
CycD/Cdk4 and CycE/Cdk2 which in vertebrates are known to phosphorylate pRb (Dyson, 
1998).  Since the regulation of RnrS expression in the epidermis of both CycD and Cdk4 
mutant embryos is normal, the modulation of CycD/Cdk4 activity may not be part of the 
mechanism (Emmerich et al., 2004; Meyer et al., 2002a).  In contrast, CycE/Cdk2, which can 
phosphorylate and inhibit Rbf1 (Du et al., 1996a), is inhibited just prior to the introduction of 
G117 by the developmentally-regulated induction of dap transcription during cycle 16 (de 
Nooij et al., 1996; Lane et al., 1996) (Figure 2.1I).  If the inhibition of CycE/Cdk2 activity by 
Dap is necessary for the accumulation of hypo-phosphorylated Rbf1 and the consequent 
suppression of E2f1 targets, then in dap mutants RnrS expression would not be terminated 
properly.  However, RnrS expression is down-regulated in the epidermis of dap mutants prior 
to the completion of S16 just as it is in wild type embryos (Figure 2.2A, B).  Moreover, the 
termination of RnrS expression occurs even though the epidermal cells of dap mutant 
embryos enter an ectopic S17 (Figure 2.2C, D). 
A similar result is seen in the epidermis of fizzy-related (fzr) mutant embryos.  fzr 
encodes Drosophila Hct1/Cdh1, which during G1 phase targets mitotic cyclins for 
ubiquitination by the APC/C and subsequent destruction (Jacobs et al., 2002; Sigrist and 
Lehner, 1997).  Similar to dap mutants, epidermal cells in fzr mutants fail to exit the cell 
cycle and inappropriately enter an ectopic S17 that is likely driven by CycE/Cdk2 (Sigrist and 
Lehner, 1997).  In spite of this, RnrS expression is properly down-regulated in fzr mutants 
(Figure 2.2E).  Thus, while unrestricted CycE/Cdk2 activity can prevent the initiation of G117 
in epidermal cells, E2f1 target gene expression is still terminated at the appropriate time.  
These data suggest that either the inhibition of CycE/Cdk2 does not result in the 
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accumulation of hypo-phosphorylated Rbf1, or that a different mechanism is involved in the 
initial termination of E2f1 target gene expression. 
 
Figure 2.2:  E2f1 target gene expression is terminated in mutants containing ectopic CycE/Cdk2.  
Embryos were pulse-labeled with BrdU for 5 minutes (A-D) or 15 minutes (E) and were stained for BrdU 
incorporation (green) and phospho-tyrosine to highlight cell boundaries (cyan).  RnrS expression was detected 
by FISH (red).  (A) Stage 10 w1118 control embryo. The bar denotes S16 in the dorsal epidermis and the bracket 
marks cycle 15 in the ventral epidermis.  (B) Stage 10 dap4454/dap4454 embryo.  Note that P-Tyr is absent 
because anti-β-Gal was used to distinguish CyO P[wg-lacZ]-containing embryos from the dap mutants.  (C) 
Control embryo that is a sibling of the embryo in panel D.  The arrow denotes cells of the anterior spiracle 
primordium that normally enter S17.  (D) Stage 11 dap4454/dap4454 embryo.  (E) Df(1)biD3/Df(1)biD3 fzr mutant 
embryo.   Scale bars are 50µm. 
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Cell cycle-regulated destruction of E2f1 protein in the embryonic epidermis 
 One possible mechanism for the inhibition of E2f1 activity is the destruction of E2f1 
protein.  In both the eye and wing imaginal discs E2f1 protein is destroyed at the G1-S 
transition and re-accumulates during G2 and M phase (Asano et al., 1996; Heriche et al., 
2003; Reis and Edgar, 2004).  We therefore postulated that E2f1 destruction during S phase 
of the post-blastoderm cell cycles contributes to the termination of E2f1 target gene 
expression in the epidermis.  To examine this, we visualized E2f1 protein abundance by 
immunofluorescence in embryos that were pulse-labeled with BrdU (Figure 2.3).   
E2f1 protein is present throughout the embryo during early syncytial cycles 1-13 
(data not shown).  Notably unlike imaginal disc cells, nuclear E2f1 was detected during S 
phase of cycles 13 and 14 (Figure 2.3A, B).  E2f1 protein accumulates to high levels in the 
nucleus during G214 (Figure 2.3C), and is then rapidly diminished when cells enter S15 
(Figure 2.3D).  This effect is post-transcriptional since E2f1 transcripts are ubiquitous during 
cycle 15 (Duronio et al., 1995), suggesting that E2f1 protein is destroyed upon entry into S 
phase.  In addition, the lack of S phase destruction of E2f1 in S13 and S14 suggests that 
zygotic gene expression, most of which begins during cycle 14, is necessary for the coupling 
of E2f1 destruction with S phase beginning in cycle 15.   
E2f1 begins to re-accumulate during G2 of cycle 15, but never attains the levels seen 
in G2 of cycle 14 (Figure 2.3E), perhaps because of the short duration of G215.  As in cycle 
15, E2f1 protein abundance is low in S16, but begins to re-accumulate in G216 (Figure 2.3E,F).  
By the time the epidermal cells enter G117, E2f1 protein has accumulated to a high level in 
the nucleus (Figure 2.3G, H), and remains at this level at least until mid-embryogenesis 
(Figure 2.3I).  A group of cells in the first and second thoracic segments do  
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Figure 2.3: E2f1 protein accumulation during embryogenesis.  w1118 embryos were pulse-labeled with BrdU 
for 5 minutes, and stained for E2f1 (green), BrdU incorporation (red) and phospho-tyrosine (cyan).  (A) 
Embryos undergoing S13.  (B) S14.  (C) G214.  (D) S15 is indicated with arrows; the remaining cells are still in 
G214.  Note that entry into M14 is not synchronous throughout the embryo, resulting in groups of cells called 
mitotic domains that proceed through the cycle coordinately and that generate a reproducible and stereotypic 
pattern of BrdU incorporation (e.g. the top arrow indicates mitotic domain 11 (Foe, 1989)).  (E) Cycle 15 in the 
ventral epidermis (bracket) and S16 in the dorsal epidermis (bar). (F) S16 in the ventral epidermis (bracket) and 
G216 -G117 in the dorsal epidermis (bar).  Arrowheads in E-H indicate amnioserosa cells.  (G, H) Most cells of 
the epidermis have entered G117, while, as described in Figure 2.2C, some cells continue into cycle 17 (arrows).  
(I) G117.  Scale bar is 50 μm. 
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not enter G117, but instead complete one more division cycle before arresting (Sauer et al., 
1995).  E2f1 protein is also down-regulated during S phase in these cells (Figure 2.3G, H, 
arrows).  These data indicate that E2f1 protein abundance is inversely correlated with S 
phase during the post-blastoderm cell division cycles. 
To determine the timing of E2f1 destruction more precisely, we compared E2f1 
abundance with the pattern of BrdU incorporation as well as with phospho-histone H3 
staining, which detects condensed mitotic chromosomes (Figure 2.4).  As reported for wing 
imaginal cells (Reis and Edgar, 2004), E2f1 protein is abundant during mitosis.  E2f1 is 
nuclear in early prophase prior to nuclear envelope breakdown (Figure 2.4A, arrowhead).  In 
metaphase and anaphase, E2f1 protein appears more diffuse, likely due to nuclear envelope 
breakdown (Figure 2.4A, large and small arrows, respectively).  E2f1 is present in newly 
formed daughter cells, suggesting that it is not destroyed by the APC/C during mitosis 
(Figure 2.4A, double arrow).  A high level of E2f1 protein is present in cells in early S phase, 
which is characterized by uniform BrdU incorporation throughout the nucleus (Figure 2.4B, 
large arrow).  In mid-S phase, where BrdU incorporation is less uniform, there is a significant 
reduction in E2f1 protein (Figure 2.4B, small arrow).  By late S phase, where the more 
punctuate BrdU incorporation pattern marks late replicating heterochromatin, there is very 
little E2f1 protein present (Figure 2.4B, arrowhead).  These data are consistent with the 
destruction of E2f1 protein after the initiation of S phase, and differs slightly from previous 
results in imaginal discs where no overlap between E2f1 staining and BrdU was detected 
(Heriche et al., 2003; Reis and Edgar, 2004).  This difference may be due to the short 
embryonic cell cycle lacking a G1 phase as compared to the canonical G1-S-G2-M disc 
cycles. 
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 Figure 2.4: E2f1 protein persists through mitosis into early S phase.  (A) Stage 8 w1118 embryo labeled with 
E2f1 (green), phospho-histone H3 (red), and phospho-tyrosine (cyan).  Prophase (arrowhead), metaphase (large 
arrow), anaphase (small arrow), and daughter cells in early interphase (double arrow) are indicated.  (B) Stage 
11 w1118 embryo labeled with E2f1 (green), BrdU (red; 5 minute pulse), and phospho-tyrosine (cyan).  Early, 
mid, and late S phase are marked by a large arrow, a small arrow, and an arrowhead, respectively.  Scale bars 
are 20µm. 
 
E2f1 staining in E2f1 mutant embryos was indistinguishable from wild type until S14 
(data not shown), suggesting that maternal protein persists until S14.  E2f1 mutant embryos 
contain a detectable amount of E2f1 protein in G214, but this amount is less than sibling 
controls (Figure 2.5A, B), indicating that zygotic E2f1 synthesis is responsible for a portion 
of the E2f1 protein found in G214.  Zygotic RnrS mRNAs rapidly accumulate in the 
epidermis during cycle 14, and then begin to decline during cycle 15 such that by the 
beginning of S16 these mRNAs are very low (Figure 2.1D, arrowhead, Figure 2.2A, Figure 
2.6).  This dynamic pattern of expression is not altered in E2f1 mutant embryos (Figure 2.5E, 
F) (Duronio et al., 1995).  These data suggest that maternal E2f1 is sufficient to induce early, 
zygotic transcription of E2f1 targets, and are consistent with the hypothesis that S phase-
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coupled destruction of E2f1 protein contributes to the decline of E2f1-regulated transcripts 
during cycle 15. 
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Figure 2.5: Maternal E2f1 protein is present at the onset of zygotic RnrS expression.  (A-D) Embryos were 
pulse labeled for 5 minutes with BrdU and stained for E2f1 (green), phospho-tyrosine (cyan), and BrdU 
incorporation (red).  (A) Sibling control at G214.  (B) E2f17172/E2f17172 embryo at G214.  (C) Sibling control at 
G214/S15.  (D) E2f17172/E2f17172 embryo at G214/S15.  E2f1 mutants were identified by the reduction in E2f1 
protein level.  (E, F) Embryos were stained for E2f1 (green) and RnrS (red).  (E) Sibling control. (F) 
E2f17172/E2f17172 embryo.  Scale bars are 50 μm. 
 
 
Figure 2.6:  RnrS expression declines during cycles 15 and 16.  (A-C) w1118 embryos were pulse-labeled with 
BrdU for 15 minutes and stained for BrdU incorporation (green).  RnrS expression was detected by FISH (red).  
(A) Stage 9 embryo at early S15.  (B) Stage 9 embryo.  The bracket denotes a region of late S15 and the line 
indicates cells in early S15.  (C)  Stage 10 embryo.  The line denotes a region of early S16.  Scale bar is 50 μm. 
 
E2f1 protein destruction is S phase-dependent 
The correlation between E2f1 disappearance and BrdU labeling suggests that either 
cell cycle progression into S phase or DNA synthesis per se triggers E2f1 destruction.  To 
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test if entry into S phase is required for the destruction of E2f1, we analyzed E2f1 protein 
levels in stg mutants, which arrest in G214 (Edgar and O'Farrell, 1990).  E2f1 accumulates to 
a high level in the epidermis of stg mutant embryos (Figure 2.7A).  Aminoserosa cells, which 
in wild type embryos permanently exit the cell cycle in G214, also accumulate high levels of 
E2f1 (Figure 2.3E-H, arrowheads).  In Cyclin E mutants, E2f1 protein is not destroyed in the 
thoracic cells that normally enter a 17th division cycle (Figure 2.3G, H), because these cells 
do not enter S phase (data not shown).  These data suggest that the destruction of E2f1 in the 
epidermis requires entry into S phase.   
 To test if DNA synthesis is required for E2f1 destruction, we analyzed double-parked 
(dup) mutant embryos.   dup encodes Drosophila Cdt1, a component of the pre-replication 
complex (pre-RC) that is required for eukaryotic DNA synthesis.  dup mutant embryos 
develop normally through cycle 15, and then display impaired DNA replication in S16 
causing cell cycle arrest and embryonic lethality (Garner et al., 2001; Whittaker et al., 2000).  
S16 is absent in dupa1 null mutants, whereas dupa3 hypomorphic mutants display weak BrdU 
incorporation during a prolonged and partial S16 (Figure 2.7B, C) (Garner et al., 2001).  dupa1 
mutants accumulate high levels of E2f1 in the epidermis, suggesting that DNA synthesis is 
necessary for E2f1 destruction (Figure 2.7B).  Interestingly, dupa3 mutants also accumulate 
high levels of E2f1 even though these epidermal cells are capable of incorporating some 
BrdU (Figure 2.7C).  This suggests that efficient progression through S phase is necessary to 
trigger E2f1 destruction, and/or that Dup plays a more direct role in E2f1 destruction. 
 S phase-dependent destruction of E2f1 protein predicts that E2f1 levels will be low 
during the ectopic S17 that occurs in dap and fzr mutants.  This would provide an explanation 
for the lack of E2f1 target gene expression even in the presence of ectopic CycE/Cdk2 that is 
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predicted to prevent Rbf1 activation (Figure 2.1I).  Indeed, E2f1 protein abundance is low 
during ectopic S17 in the epidermis of both dap and fzr mutants (Figure 2.7D, F, respectively). 
Conversely, Dap over-expression results in the accumulation of E2f1 protein throughout the 
epidermis, most likely because of the inhibition of S16 (Figure 2.7E).  These data are 
consistent with the hypothesis that the initial loss of E2f1 target gene expression results from 
the absence of E2f1, rather than from the appearance of hypo-phosphorylated Rbf1. 
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 Figure 2.7: E2f1 destruction is replication-dependent.  (A-E) Stage 11 embryos were pulse-labeled with 
BrdU for 5 minutes, and stained for E2f1 (green), BrdU incorporation (red), and phospho-tyrosine (cyan).  (A) 
stg7B/stg7B. (B) dupa1/dupa1. (C) dupa3/dupa3. (D) dap4454/dap4454; arrow indicates epithelial cells expressing low 
levels of E2f1.  (E) UAS dap/arm-Gal4 VP16. (F) Stage 11 Df(1)biD3/Df(1)biD3 fzr were pulse-labeled with 
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BrdU for 15 minutes, and stained with E2f1 (green) and BrdU (red).  Arrow indicates epithelial cells expressing 
low levels of E2f1 similar to dap mutants.  Scale bars are 50 μm. 
 
Rbf1 is not required for the initial termination of E2f1 target gene expression prior to 
G117 arrest. 
 We have demonstrated that E2f1 protein is destroyed during S15 near the time when 
RnrS expression begins to decline.  This is one cell cycle before Dap is induced to inhibit 
CycE/Cdk2 and trigger the onset of G117.  If Dap expression and the inhibition of CycE/Cdk2 
results in the accumulation of hypo-phosphorylated Rbf1 (Figure 2.1I), then RnrS expression 
is normally terminated before Rbf1 becomes active.  This model predicts that RnrS 
expression should terminate on schedule in Rbf1 mutant epidermal cells.  Indeed, both E2f1 
protein and RnrS transcripts are absent during S16 in Rbf1 mutant epidermal cells (Figure 
2.8A).  Later, as E2f1 protein re-accumulates throughout the epidermis in G216 and G117, 
RnrS transcripts inappropriately reappear in Rbf1 mutants (Figure 2.8B).  This ectopic 
expression of E2f1 target genes ultimately results in cell cycle re-entry, as previously 
described (Figure 2.8C, bracket) (Du and Dyson, 1999).  Not all Rbf1 mutant epidermal cells 
re-enter S phase, suggesting that other inputs modulate the cell cycle response to Rbf1 loss.  
This may include cell-by-cell differences in the amount of E2f1, since we observe that cells 
with the most E2f1 are usually the same ones that enter S phase inappropriately.  This is 
consistent with previous observations that transgene-mediated high level E2f1/Dp expression 
can drive most of the G117 epidermal cells into S phase (Duronio et al., 1996).  These data 
indicate that Rbf1 is not required for the initial termination of E2f1 target gene expression, 
but rather for sustained termination and stable G1 arrest. 
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 Figure 2.8: The initial termination of E2f1 target gene expression does not require Rbf1.  Rbf114 maternal 
and zygotic null embryos were pulse-labeled with BrdU for 15 minutes and stained for E2f1 (green) and BrdU 
incorporation (cyan).  RnrS expression was detected by FISH (red).  (A) Stage 10 embryo; bracket marks the 
dorsal epidermis in S16 and the bar indicates cycle 15. (B) Stage 11 embryo; the epidermal cells are in G216. (C) 
Stage 13 embryo; arrow indicates epidermal cells arrested in G117 and the bracket denotes epidermal cells 
inappropriately incorporating BrdU.  Scale bar is 50µm. 
 
Dap expression promotes conversion of Rbf1 to a repressor 
 While our data suggest that E2f1 target genes are controlled independently of Rbf1 
prior to cycle 17, it does not define the mechanism by which Rbf1 is converted to a repressor 
during G117.  To address this issue, we re-evaluated the inhibition of CycE/Cdk2 activity by 
Dap.  We hypothesized that developmentally-controlled Dap expression in cycle 16 does 
indeed convert Rbf1 to a repressor, but that Rbf1 is not required for the initial shut down of 
RnrS because other mechanisms, such as E2f1 destruction in cycles 15 and 16, are sufficient.  
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Rather, Rbf1 is required to prevent the reactivation of E2f1 target genes as E2f1 protein re-
accumulates during G216 and G117. 
The phenotype of stg mutants allowed us to test this hypothesis.  Previous 
experiments revealed that E2f1 target gene expression terminates on schedule in stg mutants 
even though stg mutant epidermal cells arrest in G214 (Duronio and O'Farrell, 1994).  This is 
an indication of a developmentally-timed event that occurs independently of cell cycle 
progression.  The high level of E2f1 protein in stg mutant epidermal cells (Figure 2.7), which 
never enter S phase, would at first seem to be at odds with this result.  However, 
developmentally controlled Dap expression in a stg mutant may inhibit CycE/Cdk2 and result 
in the accumulation of hypo-phosphorylated Rbf1 and the down regulation of E2f1 targets 
(Figure 2.1I) (Meyer et al., 2002b).  We therefore simultaneously examined Dap and RnrS 
expression in stg mutants.  In the epidermis of stg mutants at the normal time of cycle 15 (i.e. 
after gastrulation and germ band extension) RnrS transcripts are abundant and Dap protein is 
not detected (Figure 2.9A).  Later, when Dap protein accumulates, RnrS expression decreases 
(Figure 2.9B).  To test whether loss of RnrS expression in stg mutant embryos requires Dap, 
we analyzed stg dap double mutant embryos shortly after the time when Dap is first induced.  
RnrS is not suppressed in certain cells of stg dap double mutant embryos that correspond to 
cells with high levels of Dap protein in stg single mutant sibling embryos (Figure 2.9C, D, 
bracket).  These data are consistent with our model that the inhibition of CycE/Cdk2 by 
developmentally-controlled Dap expression results in the accumulation of Rbf1/E2f1 
repressor complexes.  However, as stg dap mutant embryos age, RnrS expression is 
eventually lost in many epidermal cells (Figure 2.9E).  This also occurs in the aminoserosa, 
which contains cells that have exited the cell cycle in G214 (Figure 2.9D, asterisk).  These 
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data imply the existence of Rbf1-indepenent mechanisms to extinguish E2f1 target gene 
expression.  Perhaps when cells exit the cycle, Dap-mediated Rbf1 activation terminates E2f1 
target gene transcription while additional mechanisms dramatically decrease mRNA stability. 
 
Figure 2.9: Dap expression activates Rbf1.  Embryos were stained for Dap (green) and phospho-tyrosine 
(cyan).  RnrS expression was detected by FISH (red).  (A) Stage 10 stg7B/stg7B embryo.  (B) Stage 12 stg7B/stg7B 
embryo. Brackets mark the epidermal cells and asterisks denote G214-arrested aminoserosa cells.  (C-E) 
Embryos from dap4454/+; stg7B/+ parents.  (C) Stage 11 embryo with stg7B/stg7B phenotype.  (D) Stage 11 
dap4454/dap4454; stg7B/stg7B embryo.  C and D are siblings that are stage-matched based on age, morphology and 
phospho-tyrosine staining.  Bracket in C indicates epidermal cells in which RnrS is starting to decline and Dap 
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is expressed at high levels.  Bracket in D shows the corresponding region in which RnrS levels remain high.  
Asterisk in D denotes aminoserosa cells.  (E) Stage 12 dap4454/dap4454; stg7B/stg7B embryo.  Scale bar is 50µm.   
 
Inefficient Rbf1 activation in dup mutants 
 For reasons that are unclear, dup mutants fail to terminate E2f1-dependent 
transcription in the epidermis (Whittaker et al., 2000).  dupa1 mutant epidermal cells fail to 
down-regulate RnrS at the time of S16, and dupa3 mutants still express RnrS during the 
prolonged and partial S16 (Figure 2.10A-C).  This may be explained by the high level of E2f1 
protein that accumulates in dup mutants (Figure 2.7).  However, Dap protein accumulates 
during cycle 16 in dup mutants (data not shown), and this should result in the down-
regulation of E2f1 targets as in stg mutants.  Rbf-280 expression using the prd-Gal4 driver 
suppressed the ectopic RnrS expression in dupa1 mutants, suggesting that E2f1 can still be 
repressed by hypo-phosphorylated Rbf1 in dup mutants (Figure 2.10D-G).  At later stages, 
RnrS transcripts eventually begin to decline in dup mutants (data not shown).  We suggest 
that in dup mutants Rbf1 is still converted to an active, hypo-phosphorylated form in 
response to Dap expression, but that the termination of E2f1-dependent transcription occurs 
slowly because of the abnormally high level of E2f1 protein. 
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 Figure 2.10: E2f1 target gene expression persists inappropriately in dup mutants.  (A-C) Stage 11 embryos 
were pulse-labeled with BrdU for 5 minutes, and stained for BrdU incorporation (green), and phospho-tyrosine 
(cyan). RnrS expression was detected by FISH (red).  (A) w1118.  (B) dupa1/dupa1.  (C) dupa3/dupa3.  (D-G) 
Histochemical detection of RnrS expression by in situ hybridization of dupa3 embryos (F) or embryos from 
dupa1/+; UAS Rbf-280/+ females crossed to dupa1/+; prd-Gal4/+ males (D, E and G).  (D) Sibling control 
embryo.  (E) Embryo with dupa1/dupa1 phenotype.  (F) dupa3/dupa3 embryo.   (G) dupa1/dupa1; UAS Rbf-
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280/prd-Gal4 embryo.  UAS Rbf-280 expression suppresses ectopic RnrS caused by dup mutation (arrow).  
Scale bar in A-C is 50 μm 
 
Discussion 
Our finding that p27Dap expression was not necessary for the down regulation of 
E2f1 targets was unexpected based on the known regulatory circuitry of the pRb/E2F 
pathway (Figure 2.1I).  This result led us to hypothesize that mechanisms in addition to Rbf1 
binding were used to control E2f1 activity in the early embryo.  We found that E2f1 is 
destroyed during S phase of the post-blastoderm divisions in the embryonic epidermis, as 
was previously reported for cells in wing and eye imaginal discs (Asano et al., 1996; Heriche 
et al., 2003; Reis and Edgar, 2004).  E2f1 destruction first occurs during S15 at the same time 
that E2f1-regulated transcripts like RnrS begin to decline.  Because E2f1 functions as a 
transcriptional activator, and because we show that Rbf1 is not required for the initial decline 
in RnrS transcripts, we propose that the loss of E2f1 protein contributes to the initial 
termination of replication factor gene expression.  Rbf1 is first required during development 
for the maintenance of G117 arrest and the continued repression of E2f1 target genes.  Our 
data suggest that Rbf1 is converted to a repressor after the developmentally-induced 
expression of Dap, most likely because the consequent inhibition of CycE/Cdk2 results in the 
accumulation of hypo-phosphorylated Rbf1.  Dap expression accompanies the down 
regulation of Cyclin E transcription, and each of these mechanisms of CycE/Cdk2 inhibition 
contributes to G1 arrest.  
The high level of E2f1 protein in G117 epidermal cells may permit the formation of 
E2f1-Rbf1 complexes necessary to actively and stably repress replication factor genes during 
G1 arrest (Frolov and Dyson, 2004), and also provides a simple explanation for why the loss 
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of Rbf1 function results in the ectopic expression of E2f1 targets (Du and Dyson, 1999).  
After hatching, and in response to the first instar larvae beginning to feed, the epidermal cells 
start to endoreduplicate.  Thus, the accumulation of Rbf1/E2f1 complexes during G1 arrest 
may prepare cells for rapid production of replication factors and efficient re-entry into the 
cell cycle upon activation of G1 Cyclin/Cdk complexes after growth stimulation. 
RnrS expression is lost in E2f1 zygotic mutant embryos, but not until cell cycle 17 
(Duronio et al., 1995).  One interpretation of this result is that maternal stores of E2f1 are 
sufficient for the early induction of replication gene expression in the post-blastoderm 
divisions.  Consistent with this, maternal E2f1 protein persists into cycle 14 coincident with 
the commencement of zygotic transcription of E2f1 targets like RnrS.  In addition, mutation 
of the E2f1-binding sites in the regulatory region of the PCNA gene is sufficient to abolish 
zygotic PCNA expression (Thacker et al., 2003).  However, our data do not demonstrate an 
E2f1 requirement for early zygotic RnrS expression, and E2f1 may be only one of several 
factors necessary for early zygotic expression of genes encoding replication factors (Hirose et 
al., 1993; Sawado et al., 1998; Yamaguchi et al., 1996).  For instance, the transcription of 
Cyclin E requires E2f1 in embryonic endocycles, but also occurs independently of E2f1 via 
tissue-specific enhancer elements such as those operating in the CNS (Duronio and O'Farrell, 
1995; Jones et al., 2000).  Thus, any control of replication factor gene expression by E2f1 
abundance may be modulated by other transcription factors, or bypassed entirely in certain 
cell types by E2f1-independent modes of expression. 
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Mechanisms of cell cycle-regulated E2f1 destruction 
 Our data suggest that E2f1 destruction is coupled to DNA synthesis.  CycE/Cdk2 has 
been suggested as a possible cell cycle input for E2f1 destruction in imaginal cells, because it 
is activated at the G1-S transition when E2f1 is destroyed (Heriche et al., 2003; Reis and 
Edgar, 2004).  However, CycE/Cdk2 is continuously active during the embryonic post-
blastoderm cell cycles whereas E2f1 is destroyed only during S phase (Sauer et al., 1995).  
Thus, CycE/Cdk2 is unlikely to be the only signal, and actively replicating DNA may 
provide a necessary input into E2f1 destruction.  This model is consistent with our 
observation that E2f1 destruction occurs after DNA synthesis begins, resulting in cells that 
are positive for both E2f1 and BrdU incorporation in early interphase.   
Previous studies have suggested that mammalian E2f1 is degraded by the ubiquitin-
proteasome pathway (Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et 
al., 1996; Marti et al., 1999; Ohta and Xiong, 2001).  In this pathway, E3 ubiquitin ligases 
bind to and mediate the ubiquitylation of specific proteins.  The SCF class of cullin-
dependent E3 ligases has been implicated in E2F1 destruction (Marti et al., 1999).  In 
Drosophila, genetic and cell biological evidence suggest that SCFSLMB mediates E2f1 
destruction at the G1/S transition in wing imaginal disc cells (Heriche et al., 2003).  While 
there is no evidence implicating a specific E3 ligase in the destruction of embryonic E2f1, 
there are interesting parallels with recent experiments describing the destruction of Cdt1/Dup.  
Like E2f1, Cdt1/Dup is degraded at the G1-S transition and cannot be detected during S 
phase (Thomer et al., 2004).  In vertebrates, Cdt1 destruction is mediated by two independent 
and apparently redundant mechanisms: direct Cdk2 phosphorylation that targets Cdt1 to 
SCFSKP2, and binding of PCNA to the Cdt1/Dup NH2-terminus that targets Cdt1 to Cul4DDB1 
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(Arias and Walter, 2006; Nishitani et al., 2006; Senga et al., 2006).  This latter result is 
consistent with a recent study indicating that Drosophila Dup hyper-accumulates in cells 
where DNA synthesis is attenuated (May et al., 2005).  Thus, more than one E3 ubiquitin 
ligase may participate in E2f1 destruction (Ohta and Xiong, 2001).  Determining the 
molecular mechanism of E2f1 destruction should permit us to directly test whether 
prevention of E2f1 destruction would affect replication factor gene expression in the embryo. 
 
pRb-independent E2F regulation and early animal development 
 E2F is necessary for the development of worms, flies and mice (DeGregori, 2002).  
Remarkably, however, pRb is not needed for the entirety of mouse embryonic development 
(Wu et al., 2003).  This could be due in part to redundancy with other pRb family members, 
such as p107 and p130 (Dannenberg et al., 2004).  Alternatively, a pRb-independent 
mechanism of regulating E2F activity may control S phase gene expression and cell cycle 
progression during early mammalian development.  This idea is supported by experiments 
modeling the cell cycles of early vertebrate development in cell culture using murine 
embryonic stem (ES) cells (White et al., 2005).  These pluripotent cells have a cell cycle 
composed mostly of S phase that is characterized by ubiquitous Cdk activity and the absence 
of CKIs (Faast et al., 2004; Savatier et al., 1996; Stead et al., 2002).  As in the Drosophila 
embryo, E2F-regulated transcripts are also ubiquitous even though pRb family members are 
expressed (Savatier et al., 1994; Stead et al., 2002).  Differentiation requires the lengthening 
of G1 and the negative regulation of Cdk2 activity, which is accomplished both by increases 
in the level of CKIs and by the down-regulation of Cyclin E1 expression via inhibition of 
E2F (White et al., 2005).  Thus, evolutionarily conserved regulatory mechanisms operating in 
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early development may mediate the conversion from rapid cell cycles driven by intrinsic cues 
to slower, more highly regulated cycles that are influenced by extrinsic developmental and 
environmental cues. 
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CHAPTER III 
 
DROSOPHILA E2F1 IS DEGRADED DURING S PHASE IN A PCNA-, CUL4-, AND 
CDT2-DEPENDENT MANNER 
 
 
Preface 
 This work represents a manuscript that is currently in preparation for publication. 
Along with my advisor Bob Duronio, I participated in the experimental design for this 
project. I performed the majority of the experiments described and wrote the manuscript. 
Jackson Turbyfill, an undergraduate student in the lab, analyzed the apoptosis and mitosis 
phenotype caused by the overexpression of PIP-3A mutant E2F1 in wing discs (Figure 3.8A).  
This work was carried out in collaboration with the Bruce Edgar lab in the Fred Hutchinson 
Cancer Research Center, who analyzed the larval salivary gland phenotype (Figure 3.9). 
 Abstract 
Our previous finding suggests that the destruction of Drosophila E2F1 is dependent 
on DNA replication (Chapter III), leading us to investigate the mechanism that links DNA 
replication and E2F1 destruction. Here, using Drosophila S2 cells, we found that E2F1 is 
degraded during S phase in a PCNA-, Cul4-, and Cdt2-dependent manner. This suggests that 
a common destruction mechanism is used for the destruction of E2F1 and Cdt1, a member of 
the pre-replication complex. In addition, we found that the destruction of E2F1 is dependent 
on its partner DP, but not on CDK-mediated phosphorylation or RBF1-binding. The 
expression of a stabilized mutant of E2F1 in the wing imaginal disc induced massive 
apoptosis, resulting in abnormal morphology of the adult wing. This suggests that the S 
phase-dependent destruction of E2F1 is required for the normal development of Drosophila, 
and implicates the existence of a sensor that detects inappropriate E2F1 expression during S 
phase and subsequently activates apoptotic pathways. 
 
Introduction 
 In the previous chapter, we showed that the initial downregulation of E2F1-target 
gene expression is independent of RBF1 and Dap. Instead, we showed the developmentally-
regulated onset of E2F1 protein destruction as a possible mechanism regulating this initial 
downregulation of E2F1-target genes. Interestingly, the destruction of E2F1 was observed 
specifically during S phase, leading us to investigate the mechanism that links S phase and 
E2F1 destruction. 
 Mammalian E2F1 is degraded in S/G2 by the ubiquitin-mediated proteolysis. The 
Cul1SKP2 ubiquitin ligase complex binds to the N-terminus of E2F1, and the N-terminal 
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truncation of E2F1 stabilized the protein (Marti et al., 1999). Other labs showed that the C-
terminal truncation of mammalian E2F1, 2, and 4 stabilized these proteins, and that co-
expression of pRB protected E2F1 from ubiquitination and subsequent destruction 
(Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996). In 
Drosophila, the Cul1Slmb ubiquitin ligase was previously linked to E2F1 destruction. Heriche 
et al. showed that E2F1 is stabilized by the overexpression of a putative dominant negative 
Cul1 (mouse Cul1) and by a mutation of slmb. However, the stabilization of E2F1 during S 
phase they observed was incomplete (e.g. only 3% of S phase cells were E2F1 positive in 
mouse Cul1-overexpressing wing discs) (Heriche et al., 2003), suggesting the existence of 
other ubiquitin ligases which target Drosophila E2F1 for destruction. In addition, Drosophila 
E2F1 is degraded in early S phase  (Asano et al., 1996; Heriche et al., 2003; Reis and Edgar, 
2004) (Figure 2.4), showing a difference in the timing of destruction between Drosophila and 
mammalian E2F1 (early S in Drosophila vs. S/G2 in mammals). Here we show that 
Drosophila E2F1 is degraded during S phase in a PCNA-, Cul4-, and Cdt2-dependent 
manner, which resembles the destruction of Cdt1, a pre-replication complex member (Arias 
and Walter, 2006; Jin et al., 2006; Senga et al., 2006). The destruction of E2F1 is also 
dependent on its partner DP, but not affected by mutations in the putative CDK 
phosphorylation sites or the RBF1-binding site. Furthermore, we examined the in vivo 
significance of E2F1 destruction and found that the stabilized version of E2F1 induces 
massive apoptosis when expressed in the wing imaginal disc, resulting in disturbed 
morphology of the adult wing. These results suggest that the S phase-dependent destruction 
of E2F1 is an essential feature for the normal development of Drosophila. We propose that 
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cells may possess an S phase-specific sensor which detects ectopic E2F1 activity and 
subsequently activates apoptotic pathways. 
 
Materials and Methods 
PCR primers  
Primers for pENTR-D-TOPO cloning: 
E2f1 (1-) pENTR forward 
CACCATGTCCAAGTTCTTTGTGAATGTTGCC 
E2f1 (47-) pENTR forward 
CACCATGGTGGCCCGCAGACTCAACTA 
E2f1 (93-) pENTR forward 
CACCGGCGGCGTGGCAGCCCACC 
E2f1 (139-) pENTR forward 
CACCCAAAATCAGCAGCAACGCAAGG 
E2f1 (231-) pENTR forward 
CACCTCGCTGTCGACGCCCCAGCAAC 
E2f1 (529-) pENTR forward 
CACCCAGCAACAACAACAGTTGCTACAGC 
E2f1 (-92) pENTR reverse 
TCAGTTGCTGTTGCTGTCGCTGCTGC 
E2f1 (-138) pENTR reverse 
TCAGTGGTGGTGCTGCTGCTGCAG 
E2f1 (-184) pENTR reverse 
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TCACGTCTGGTGGTGGGCGCTCTG 
E2f1 (-230) pENTR reverse 
TCAAAAGGGGTGATGCGATGCCGG 
E2f1 (-528) pENTR reverse 
TCACTGCTGCTGCTGGTTCAGATTATG 
E2f1 (-805) pENTR reverse 
TTAGGGTCCATAGGCATCCGAACCGAA 
Cul4 pENTR forward  
CACCATGAGTGCGGCCAAGAAGTACAAG 
Cul4 pENTR reverse  
TTATGCCACATAGTTGTATTGGTTTTG 
Cdt2 (l(2)dtl) pENTR forward  
CACCATGAACATTTACAACAAGTTGCGGGC 
Cdt2 (l(2)dtl) pENTR reverse  
TCAATCGCTGCCCACCGCCGTC 
 
Primers for pDONR221 cloning: 
Dp pDONR forward 
GGGGACAAGTTTGTACAAAAAAGCAGGCTCCATGGCGCATTCGACGGGC
GGTAC 
Dp pDONR reverse 
GGGGACCACTTTGTACAAGAAAGCTGGGTTCAATCAATGTCGTCGTCCAG
CTC 
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Primers for mutagenesis: 
E2f1 L786Q mutagenesis forward 
CTATCCGTATGCGCAGAACGCGAACGAGG 
E2f1 L786Q mutagenesis reverse 
CCTCGTTCGCGTTCTGCGCATACGGATAG 
E2f1 PIP-3A mutagenesis forward 
GACCGGCAAATCCAACGATGCCACAAATGCCGCCAAGGTCAAACGTCGG
CCAC 
E2f1 PIP-3A mutagenesis reverse 
GTGGCCGACGTTTGACCTTGGCGGCATTTGTGGCATCGTTGGATTTGCCGG
TC 
E2f1 PIP-7A mutagenesis forward 
GGCGACCGGCAAATCCGCCGCAGCAGCGGCCGCGGCCAAGGTCAAACGT
CGG 
E2f1 PIP-7A mutagenesis reverse 
CCGACGTTTGACCTTGGCCGCGGCCGCTGCTGCGGCGGATTTGCCGGTCG
CC 
E2f1 PIP-7del mutagenesis forward 
GGCGACCGGCAAATCCAAGGTCAAACGTCGGC 
E2f1 PIP-7del mutagenesis reverse 
GCCGACGTTTGACCTTGGATTTGCCGGTCGCC 
 
Primers for dsRNA synthesis: 
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Cul1 dsRNA forward  
TAATACGACTCACTATAGGG CTGCTCAACGCAGACCG 
Cul1 dsRNA reverse  
TAATACGACTCACTATAGGG TGTCCTGCAGTTGCTGG 
Cul4 dsRNA forward 
TAATACGACTCACTATAGGG TTGGCCAAACGATTACTTGTGGG 
Cul4 dsRNA reverse 
TAATACGACTCACTATAGGG GAGAAGATTATGGCTCAGCG 
Skp1 (SkpA) dsRNA forward 
TAATACGACTCACTATAGGG TGCCCAGCATCAAGTTGCAATCTTC 
Skp1 (SkpA) dsRNA reverse 
TAATACGACTCACTATAGGG CTAGCTGTTTCAACTTAATGTTGGTC 
Ddb1 dsRNA forward 
TAATACGACTCACTATAGG CCCCGCTCCATTCTGATGACC 
Ddb1 dsRNA reverse 
TAATACGACTCACTATAGGG CTGCAGCAGCGTGATGGAGCGC 
Cdt2 (l(2)dtl) dsRNA forward 
TAATACGACTCACTATAGGG GCGGGCTCCGGCATACGCGGC 
Cdt2 (l(2)dtl) dsRNA reverse 
TAATACGACTCACTATAGG CGTGGCTGGAGCCCCAGGCCACG 
Slmb dsRNA forward 
TAATACGACTCACTATAGGG GGCCGCCACATGCTGCG 
Slmb dsRNA reverse 
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TAATACGACTCACTATAGGG CGGTCTTGTTCTCATTGGG 
Skp2 (CG9772) dsRNA forward 
TAATACGACTCACTATAGGG TAGACCAGGTGCCCTCG 
Skp2 (CG9772) dsRNA reverse  
TAATACGACTCACTATAGGG GGTTGCTGGAATAAGATAGC 
Ago dsRNA forward 
TAATACGACTCACTATAGGG GATGCCCAGCTGCTAGC 
Ago dsRNA reverse 
TAATACGACTCACTATAGGG TGCTGGCGAGGGATTCG 
Dp dsRNA forward  
TAATACGACTCACTATAGGG GGCCCAGAACAAGTCCGAAATGG 
Dp dsRNA reverse 
TAATACGACTCACTATAGGG GGCAAGGTTTGGAGGCACCCAC 
Rbf1 dsRNA forward 
TAATACGACTCACTATAGGG AAGCTGGCGAAGAGGTAATAGCC 
Rbf1 dsRNA reverse 
TAATACGACTCACTATAGGG GCACACATAATATTTTGATCGAGGTG 
Pcna dsRNA forward 
TAATACGACTCACTATAGGG CAGGCCATGGACAACTCCCATG 
Pcna dsRNA reverse 
TAATACGACTCACTATAGGG TGTCTCGTTGTCCTCGATCTTGGG 
lacZ dsRNA forward  
TAATACGACTCACTATAGGG ACGCCGAACGATCGCCAGTTCTG 
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lacZ dsRNA reverse  
TAATACGACTCACTATAGGG CGAGCCAGTTTACCCGCTCTGC 
 
Primers for RT-PCR: 
Cul1 RT-PCR forward 
GCATCTGCAACTACCTGAATCGG 
Cul1 RT-PCR reverse 
CAGATTCTGAAACTCGGTGTGAAAG 
Cul4 RT-PCR forward 
CGTCACTATCTGGACTCGAGCAC 
Cul4 RT-PCR reverse 
CCAGATCGCAGTTTCATATCTACG 
Ddb1 RT-PCR forward 
GGTCTCTAAAGGTGGGAGTCG 
Ddb1 RT-PCR reverse  
GTAGATGGTCTCAAGATCAGGCAG 
Cdt2 (l(2)dtl) RT-PCR forward  
AATATTTTCGATGCCTCGAAGGTTG 
Cdt2 (l(2)dtl) RT-PCR reverse  
CACCTCCCACAGTCTGGCAGTG 
Dp RT-PCR forward  
GTACGACAACAACTGTGATCAAAAG 
Dp RT-PCR reverse  
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TTCGCCAGTCTTGCCGGTGCC 
Pcna RT-PCR forward  
CTTCGATTGCAGCGACTCCGGC 
Pcna RT-PCR reverse  
AAATGTCAGCGTCACCGGCTCC 
Slmb RT-PCR forward  
CAACCACTATGCTGTACGACCCG 
Slmb RT-PCR reverse 
TCCGCCAGTTGTTCTCTATGCTG 
Ago RT-PCR forward  
GCTCGCGAGACGCAACCTTGAG 
Ago RT-PCR reverse  
GACCGCAGAATGATGCTTATTTGG 
Skp2 (CG9772) RT-PCR forward  
TCACTGTCGATGTCCCGTCAATC 
Skp2 (CG9772) RT-PCR reverse  
TTGTCCGCAAACCCAAATCTAGCC 
Skp1 (SkpA) RT-PCR forward  
TGCCCAGCATCAAGTTGCAATCTTC 
Skp1 (SkpA) RT-PCR reverse  
CAAATCCAATTCGTTCCCGAATCC 
Rbf1 RT-PCR forward  
GTGGTCAAGGGTAATTGTGTGTCC 
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Rbf1 RT-PCR reverse  
CGAAGTTTTCGTTAGCCAATAGGCC 
 
Plasmid vectors 
The open reading frames (ORFs) of the wild type or ΔCDK mutant E2f1 were 
amplified from pUAST-E2f1 or pUAST-E2f1ΔCDK (gifts from Dr. Bruce Edgar), respectively, 
and cloned into pENTRTM/D-TOPO® (Invitrogen). The forward primers used to amplify E2f1 
were designed to contain CCAC at the 5’ end for the directional cloning into pENTR. E2f1 
mutants containing L786Q, PIP-3A, PIP-7A and PIP-7del mutations were created from 
pENTR-E2f1 using a QuikChange® II Site-Directed Mutagenesis Kit (Stratagene). For the 
deletion assay shown in Figure 3.1, the DNA sequences coding amino acids 1-230, 231-528, 
529-805, 1-92, 47-138, 93-184 and 139-230 of E2f1 were amplified from pENTR-E2f1 and 
cloned into pENTR. The ORFs of Cul4 and Cdt2 (l(2)dtl) were amplified from cDNA clones 
(DGC clone LP02965 and LD21681, obtained from Open Biosystems) and cloned into 
pENTR. The ORF of Dp was amplified from a cDNA (gift from Dr. Nick Dyson) and cloned 
into pDONRTM221 (Invitrogen) using the Gateway® BP Clonase™ II enzyme mix 
(Invitrogen). The ORFs inserted in pENTR or pDONR were confirmed by sequencing. To 
create expression vector plasmids, the pENTR or pDONR plasmids were recombined with 
pAGW (Actin promoter, N-term GFP), pHGW (Hsp70 promoter, N-term GFP), pAMW 
(Actin promoter, N-term myc), pAHW (Actin promoter, N-term HA), or pPGW (UASp, N-
term GFP) (provided by Dr. Terence Murphy using the Gateway® LR Clonase™ II enzyme 
mix (Invitrogen). 
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Cell culture and transfection 
Schneider S2 cells were provided by Dr. Steve Rogers. Cells were routinely grown at 
room temperature in Schneider’s Drosophila medium (Gibco) supplemented with 10% Fetal 
Bovine Serum (Sigma) and 1:200 Penicillin-Streptomycin (5 units/ml Penicillin, 5 μg/ml 
Streptomycin, Sigma). For transfection and RNAi assay, cells were grown at 28˚C. 
 For transfection, S2 cells diluted to 5×105 cells/ml were plated in 6 well plates (1.6 ml 
culture per well) and grown for a day until transfection. For transient transfection with 
pAGW, pAMW or pAHW plasmids, cells were transfected with 1.2 μg per well (pAHW-
Cul4 and pAHW-Cdt2, when transfected with pAMW-E2f1PIP) or with 0.4 μg per well (other 
constructs) of plasmid using Effectene® (Qiagen), and subjected to analyses at 2 or 3 days 
after transfection. For stable transfection with pAGW or pHGW plasmids, cells were 
transfected with 0.4 μg per well of expression plasmid along with 0.02 μg per well of 
pCoHygro (Invitrogen). 2 or 3 days after transfection, the medium was replaced with fresh 
growth medium, and cells were allowed for 2 days to grow. Cells were then incubated in 
growth medium containing 500 μg/ml hygromycin B (Invitrogen) for more than 18 days for 
the selection of stably-transfected cells. 
 
Flow cytometry  
Transiently or stably transfected S2 cells were collected in microcentrifuge tubes and 
washed once with PBS at room temperature, fixed with ice-cold 1% paraformaldehyde in 
PBS for 30 min on ice, washed once with ice-cold PBS, and permeabilized with PBT (PBS 
containing 0.1% Tween20) for 15 min at room temperature. Then 3 μl per tube of 500 μg/ml 
DNase-free RNase (Roche) were added, followed by 30 min incubation at 37˚C. DNA was 
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stained with 400-500 μl per tube of ice-cold 15 μM propidium iodide in PBS overnight at 4˚C. 
Flow cytometry was performed using a CyAn (Dako), and the data was analyzed with the 
Summit 4.3 software (Dako). Percentages of G1, S, and G2 were calculated using the ModFit 
LTTM software (Verity Software House). 
 
RNAi 
Double stranded RNAs (dsRNAs) were transcribed from PCR products which are 
gene-specific sequences flanked by the T7 promoter sequences. PCR products were 
amplified from genomic DNA or cDNA clones. Transcription reaction was performed using 
the RiboMAXTM Large Scale RNA Production System-T7 (Promega) in 50 μl volume with 
20 μl of PCR product. Synthesized RNAs were treated with 0.1 units/μl of RNase-free RQ1 
DNase (Promega) for 15 min at 37˚C. Complementary RNA strands synthesized were 
denatured by incubating the RNAs for 2 min on a 95˚C heat block, and annealed to form 
dsRNAs by transferring the heat block to room temperature. dsRNAs were then cleaned with 
illustraTM Sephadex™ G-50 columns (GE Healthcare). Approximate concentrations of the 
dsRNAs were determined by comparing the intensity of RNA bands in an agarose gel using a 
dsRNA ladder (New England Biolabs) as a standard. The intensity of the RNA bands were 
analyzed using an AlphaImagerTM 2200 (Alpha Innotech) and the AlphaEaseFCTM 3.2 
software (Alpha Innotech). 
For RNAi, S2 cells stably transfected with pHGW-E2f1 were grown in Sf-900II 
serum free medium (Gibco) supplemented with 1:200 Penicillin-Streptomycin. Cells diluted 
to 1×106 cells/ml were plated in 6 well plates (1 ml per well), and grown for a day at 28˚C. 
dsRNAs of indicated amounts (see Figure 3.4) were then added to cells. After 2 days of 
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incubation at 28˚C, a subset of the cells was used for RT-PCR and Western blot, and the rest 
was heat-shocked for 30 min at 37˚C, fixed at 225 min after the end of heat-shock, and 
subjected to flow cytometry analysis.  
 
Multiple alignment 
Multiple alignment of E2F1 fragments shown in Figure 3.2 was created using 
ClustalW2 on the EMBL-EBI website (http://www.ebi.ac.uk/Tools/clustalw2/index.html). 
 
RT-PCR 
Total RNA was extracted from S2 cells using TRIzol® (Invitrogen) according to 
manufacture’s protocol. 1 μg of total RNA was used for reverse transcription with M-MLV 
reverse transcriptase (Invitrogen) in 20 μl volume. 0.5 μl of the 20 μl reaction was used for 
subsequent PCR with GoTaq® Flexi (Promega) for 27 or 30 cycles. 
 
Co-immunoprecipitations and Western blotting 
S2 cells transiently transfected with pAMW-E2f1 constructs and/or pAHW constructs 
(Cul4, Cdt2, or Dp) were washed once with PBS and lysed with 500 μl of ice-cold lysis 
buffer (50mM Tris-HCl pH8.3, 150mM NaCl, 0.5% NP40) containing protease inhibitors (1 
μg/ml leupeptin, 0.5 μg/ml pepstatin and 1 mM PMSF). After equalizing the concentrations 
of all samples, 300 μl of lysate was incubated overnight at 4˚C with 25 μl of Protein G 
SepharoseTM 4 Fast Flow (GE Healthcare) which was pre-incubated with a mouse anti-myc 
(1:500) antibody (gifts from Dr. Eric Wagner). Immunoprecipitates were then washed four 
times with lysis buffer, and analyzed by Western blot. 
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For Western blot using wing disc lysates, ~20 wing discs were dissected from 3rd 
instar larvae, and lysed with 200 μl of ice-cold lysis buffer (50mM Tris-HCl pH8.3, 150mM 
NaCl, 0.5% NP40) containing protease inhibitors. Protein concentrations were measured by 
the Bradford assay, and 5 μg of protein was loaded in each lane. 
Cell/tissue lysates and immunoprecipitates were subjected to SDS-PAGE using 10% 
or 12% Tris-HCl Ready Gels (Bio-Rad). Proteins were transferred to Trans-Blot® 0.45 µm 
nitrocellulose membranes (Bio-Rad) and detected with the following primary antibodies: 
mouse anti-myc (1:2000, gift from Dr. Eric Wagner), mouse anti-HA (1:50000, gift from Dr. 
Eric Wagner), rabbit anti-Cul1 (1:250, Invitrogen-Zymed), rabbit anti-Cul4 (1:10000, gift 
from Dr. Sima Zacharek and Dr. Yue Xiong), mouse anti-Ddb1 (1:100, Invitrogen-Zymed), 
mouse anti-DP (YUN1-3, 1:4, gift from Dr. Nick Dyson (Du et al., 1996), rabbit anti-E2F1 
(1:100, raised against full length Drosophila E2F1, and affinity purified against full length 
E2F1 polypeptide), and mouse anti-alpha tubulin (1:2000, Sigma). Secondary antibodies 
were ECL™ sheep anti-mouse HRP (1:2000) and ECL™ donkey anti-rabbit HRP (1:2000) 
from GE Healthcare. 
 
Drosophila strains 
UASp-E2f1, UASp-E2f1PIP-3A, UASp-E2f1PIP-7A, and UASp-E2f1PIP-7del transgenic 
flies were created by injecting w1118 embryos with pPGW vectors containing the wild type, 
PIP-3A, PIP-7A or PIP-7del mutant E2f1 ORFs, respectively. Injection was performed by 
Rainbow Transgenic Flies, Inc. (Newbury Park, CA). UAS-GFP, prd-GAL4/TM3, and arm-
GAL4 were obtained from the Bloomington Stock Center. en-GAL4 was a gift from Dr. 
Steve Crews. 
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RNA in situ hybridization 
In situ hybridization was performed as described (Shibutani et al., 2007). Embryos 
were dechorionated with 50% bleach, fixed in a 1:1 mixture of 4% formaldehyde in 
PBS/heptane for 25 min at room temperature, and devitellinized with methanol. Embryos 
were stored in methanol at -20˚C. A digoxigenin-labeled RnrS probe was synthesized by 
transcribing antisense RNA from a full length RnrS cDNA (DGC collection clone LD41588, 
obtained form Open Biosystems). Stained embryos were mounted with Fluoromount-G 
(Southern Biotech) and visualized with a Nikon Eclipse E800 microscope. 
 
BrdU labeling and immunostaining 
For staining embryos with anti-GFP, anti-phosphotyrosine and anti-BrdU, 
dechorionated embryos were permeabilized with octane, pulse-labeled with 1 mg/ml BrdU 
for 5 min in Schneider’s medium prior to fixation. Embryos stored in methanol were re-
hydrated with PBT and incubated with rabbit anti-GFP (1:10000, Upstate) overnight at 4˚C. 
To detect GFP, the TSATM Fluorescein System (Perkin Elmer) was used with a biotin-
conjugated anti-rabbit secondary antibody (1:1000, Chemicon). Embryos were then 
incubated with rat anti-phosphotyrosine (1:100, R&D Systems), followed by donkey anti-rat-
Cy5 (1:500, Jackson). After re-fixation with 4% formaldehyde in PBS for 25 min at room 
temperature, BrdU was detected by acid denaturation of chromosomes, mouse anti-BrdU 
(1:100, Becton Dickinson), and goat anti-mouse-Cy3 (1:500, Jackson).  
For staining wing discs with anti-cleaved Caspase-3, flies were allowed to lay eggs 
for a day, and the eggs were incubated at 25˚C until they reach the 3rd instar larva stage. 
Wing discs were dissected from 3rd instar larvae in Schneider’s medium, fixed with 6% 
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paraformaldehyde in PBS for 20 min at room temperature. After three washes with PBS, 
discs were incubated with 5% normal goat serum in PBT for 1h at room temperature, and 
incubated with rabbit anti-cleaved Caspase-3 (Asp175) (1:200, Cell Signaling Technology) 
overnight at 4˚C. Discs were then incubated with goat anti-rabbit-rhodamine (1:1000, 
Invitrogen-Molecular Probes), and 1 μg/ml DAPI. 
For staining S2 cells with anti-BrdU, S2 cells stably transfected with pHGW-E2f1 
constructs were heat-shocked for 30 min at 37˚C, and pulse-labeled with 10 μg/ml BrdU in 
growth medium for the last 45 min prior to fixation. Cells were plated on a Concanavalin A-
treated cover glass during incubation with BrdU, and fixed at 225 min after the end of the 
heat shock. Fixation was performed with 4% paraformaldehyde in PBS for 20 min at room 
temperature. Cells were then permeabilized with PBT for 15 min at room temperature, and 
the chromosomes were denatured by incubation with 50 units/ml RNase-free RQ1 DNase 
(Promega) in RQ1 DNase buffer (Promega) for 30 min at 37˚C. After blocking with 5% 
normal goat serum in PBT for 30 min at room temperature, cells were incubated with mouse 
anti-BrdU (1:100, Becton Dickinson) overnight at 4˚C. Cells were then incubated with goat 
anti-mouse-Cy3 (1:500, Jackson), and 5 μg/ml DAPI.  
Stained embryos, wing discs and cells were mounted with Fluoromount-G. Embryos 
and wing discs were visualized with a Zeiss LSM 510 scanning confocal microscope. Cells 
were visualized with a Nikon Eclipse E800 microscope. Images were consistently modified 
with Photoshop® CS2 9.0 (Adobe) 
 
Imaging of adult wings 
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 Adult wings were dissected from CO2 anaesthetized flies, mounted on a slide glass, 
and visualized with a Nikon Eclipse E800 microscope. 
 
Results 
Detection of the S phase-specific E2F1 destruction in S2 cells 
In the previous chapter, we showed that Drosophila E2F1 protein destruction begins 
prior to differentiation during embryogenesis, and that this destruction is strictly dependent 
on S phase. We wished to understand the mechanism that underlies the S phase-specific 
destruction of E2F1. To this end, we first established a flow cytometry (FACS)-based 
experimental system that allows us to detect S phase-specific destruction of E2F1. S2 cells 
were transfected with plasmids to express GFP or GFP-E2F1 (GFP at the N-terminus of 
E2F1) under the control of the Actin promoter, and stable transfectants were selected with 
hygromycin. The transfected cells were fixed, stained for DNA, and analyzed by FACS. 
Figure 3.1 shows cell cycle profiles of all cells and GFP positive cells. GFP positive cells 
were defined by the cutoff value of GFP level above which very little non-transfected cells 
are detected (0.1% of total cells). These profiles show clear G1 and G2 peaks; G2 cells 
contain twice as much DNA as G1. S phase cells can be detected between these peaks on the 
histogram.  
To visualize the S phase-specific destruction of GFP-E2F1, we overlapped the cell 
cycle profiles of all cells and GFP positive cells (note that the Y axis is shown in a relative 
scale between all cells and GFP positive cells, because the total number of the GFP positive 
cells is always less than that of all cells). This way, S phase-specific destruction of GFP-
E2F1 was successfully visualized as a decrease in the S phase percentage of GFP-E2F1 
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positive cells (Figure 3.1A, bottom panel). Such a decrease was not observed in the GFP-
only control (Figure 3.1A, top panel). In the following experiments, we used this FACS-
based experimental system to investigate the mechanism of E2F1 destruction. 
 
Figure 3.1: The S phase-specific destruction of E2F1 is regulated by its N-terminus in S2 cells 
Cell cycle profiles of all cells (unfilled solid line), and GFP positive cells (filled in green). The GFP positive 
gate was determined as 99.9% of non-transfected cells are excluded from the gate. Note that the scales of Y axis 
are different between “all cells” and “GFP positive cells,” since GFP positive cells are a subset of all cells. 
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Percentages of S phase cells for all cells and GFP positive cells are shown in insets. S phase-specific destruction 
is detected as a decrease in the S phase percentages in the GFP positive population. 
(A) Cell cycle profiles of S2 cells stably transfected with pAGW (GFP under Actin promoter) or pAGW-E2f1 
(GFP-E2F1 under Actin promoter).  
(B) A diagram of E2F1 constructs used in C. + and – indicate the existence of S phase-specific destruction of 
GFP-E2F1 variants according to the data shown in C. The shadowed region (amino acids 139-184) is indicates a 
necessary fragment for S phase-specific destruction. PIP, PCNA-interaction protein box. DNA, DNA-binding 
domain. DP, DP-dimerization domain. MB, marked box. TA, transactivation domain. RBF, RBF1-binding site. 
(C) Cell cycle profiles of S2 cells transiently transfected to express GFP-E2F1 variants under the Actin 
promoter.  
 
The N-terminus of E2F1 is sufficient to induce the S phase-specific destruction 
Having established the experimental system, we sought to identify what aspect of the 
E2F1 protein is controlling its own destruction. We transfected S2 cells with the E2F1 
variants shown in Figure 3.1B. These E2F1 variants were N-terminally tagged with GFP, and 
expressed under the Actin promoter. As a quick way to examine various constructs, we 
employed transient expression, instead of creating stable transfectants. Despite the low 
transfection efficiency (typically 5-10%), we were still able to observe S phase-specific 
destruction (compare the GFP-only control (GFP) and GFP-E2F1 wild type (WT) in Figure 
3.1C). 
The previous report by Reis et al. suggested that increased CDK activity 
downregulates E2F1 transcripts and proteins (Reis and Edgar, 2004). Also, it has been 
reported that Slmb, the substrate receptor for a Cul1-based ubiquitin ligase, binds to E2F1 in 
a phosphorylation-dependent manner (Heriche et al., 2003). If the phosphorylation of E2F1 
by CDK promotes E2F1 destruction via Cul1-mediated ubiquitination, then mutations in the 
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CDK phosphorylation sites of E2F1 should stabilize the protein. To test this, all seven 
putative CDK phosphorylation sites (TP or SP) were mutated to alanines (E2F1ΔCDK). 
However, E2F1ΔCDK was still degraded during S phase (Figure 3.1C). It should be noted that 
we observed a slight increase in the percentage of G1/early S phase cells in the GFP-
E2F1ΔCDK positive population (Figure 3.1C and 3.2D). However, we did not pursue to 
determine whether this increase is due to the moderate stabilization of E2F1 or it is within a 
range of experimental variability. Despite the possible stabilization of E2F1 in G1/early S 
phase, the data shows that CDK phosphorylation is not the main contributor of the E2F1 
destruction during S phase. 
We next tested E2F1L786Q. This point mutation was found in the E2f1su89 mutant 
allele, and biochemical data indicate that this mutation abolishes the ability of E2F1 to bind 
RBF1 (Weng et al., 2003). It is suggested that human E2F1 is protected from ubiquitination 
and subsequent destruction when bound by pRB (Campanero and Flemington, 1997; 
Hateboer et al., 1996; Hofmann et al., 1996). If this is the mechanism that underlies the S 
phase-specific destruction (or G1/G2-specific protection) of Drosophila E2F1, then the 
L786Q mutation should destabilize E2F1 throughout the cell cycle. However, we observed a 
normal S phase destruction pattern of E2F1L786Q (Figure 3.1C), suggesting that the protection 
by RBF1 is not the mechanism that dictates the S phase-specific destruction of E2F1. 
We then asked which region of the E2F1 protein is sufficient to induce destruction. 
To this end, we first examined amino acids 1-230, 231-528 and 529-805 (Figure 3.1C). 
Surprisingly, the 1-230 fragment, in which no conserved motifs have been reported, was 
sufficient to induce the S phase-specific destruction. In contrast, destruction was not 
observed for the 231-528 or 529-805 fragments. To further delineate the region, we created 
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four smaller, overlapping fragments within the 1-230 region (1-92, 47-138, 93-184 and 139-
230), and found that the 93-184 and 139-230 fragments are degraded during S phase, 
whereas the 1-92 and 47-138 fragments are not (Figure 3.1C). These results suggest that 
there is a sequence that controls S phase-specific destruction within the region of amino acids 
139-184. 
 
The PIP box in E2F1 is required for the S phase-specific destruction 
When the 139-184 region was aligned with the putative E2F1 orthologs from the 11 
other Drosophila species, it was shown that the amino acid sequences within this region are 
highly conserved between these Drosophila species (Figure 3.2A). With help from Dr. 
Johannes Walter, we were able to find a putative “PIP box” motif (PCNA-interaction protein 
box) in this region. In this putative PIP box, the hydrophobic residue (I153 in D. 
melanogaster) and the following two consecutive aromatic residues (Y156 and Y157 in D. 
melanogaster) that characterize the PIP box are conserved in all Drosophila species. 
However, it does not contain the glutamine residue which is normally conserved in the PIP 
box (Moldovan et al., 2007). Previously, the PIP box was shown to be conserved in Cdt1, a 
member of the pre-replication complex. Cdt1 is degraded during S phase via the binding of 
Cdt1’s PIP box to PCNA (Arias and Walter, 2006; Jin et al., 2006; Senga et al., 2006). These 
studies suggest that Cdt1 binds to S phase-specific, chromatin-bound PCNA, and this 
interaction triggers the ubiquitination of Cdt1 by the Cul4Ddb1-Cdt2 ubiquitin ligase complex.  
In order to test whether the putative PIP box is required for the S phase-specific 
destruction of E2F1, we created three different PIP mutant alleles of E2f1 by mutagenesis, 
named PIP-3A, PIP-7A and PIP-7del (Figure 3.2A). PIP-3A contains three amino acid 
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mutations to alanines in the conserved I153, Y156 and Y157. The characteristics of these 
amino acids were also conserved in Cdt1’s PIP box (Figure 3.2A). PIP-7A and PIP-7del were 
created because of the possibility that the PIP-3A mutation may not completely abolish the 
ability of E2F1 to bind factors involved in its destruction, such as PCNA. 
We first attempted to obtain S2 transfectants which stably express GFP-E2F1PIP-3A 
under the control of the Actin promoter. Cells were transfected with GFP, GFP-E2F1WT or 
GFP-E2F1PIP-3A. After selection with hygromycin, stable transfectants expressing GFP or 
GFP-E2F1WT were obtained (Figure 3.1A). However, no selection-resistant cells of GFP-
E2F1PIP-3A were recovered, suggesting that the constitutive expression of E2F1PIP-3A under the 
Actin promoter causes lethality, whereas cells can survive with the expression of wild type 
E2F1 under the same promoter. 
To circumvent the lethality by E2F1PIP, we employed inducible expression of 
transgenes under the control of the Hsp70 promoter. Since the expression is induced only 
when cells are heat-shocked, the lethality caused by the expression of E2FPIP should not be 
seen at maintenance temperatures (room temperature to 28˚C). Indeed, stable transfectants of 
the PIP mutants were obtained with the Hsp70 promoter. To determine the optimal timing for 
detection of the S phase-specific destruction, a time course observation of GFP-E2F1WT 
expression was performed (Figure 3.2B). Before heat shock treatment, cells expressed very 
low, if any, levels of GFP-E2F1WT (Figure 3.2B and data not shown). Cells were treated with 
a 30 min heat shock at 37˚C to induce GFP-E2F1WT expression. At 45 min post heat shock, 
GFP-E2F1WT expression was seen in all cell cycle phases. At later time points (105, 165, 225 
and 285 min), we observed a progressive decrease in the S phase percentage of GFP-E2F1WT 
expressing cells, indicating that the destruction of GFP-E2F1WT is a dynamic process. In 
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addition, we observed an increase in S phase population induced by GFP-E2F1WT expression 
(29% S phase cells before heat shock vs. 42% at 285 min), suggesting that the GFP-tagged 
version of E2F1 retains the ability to promote the G1-to-S transition. 
 
Figure 3.2: The PIP box is required for the S phase-specific destruction of Drosophila E2F1 in S2 cells 
(A) A multiple alignment of E2F1 orthologs in 12 Drosophila species. Amino acids 139 and 184 of D. 
melanogaster E2F1 are indicated. A potential PIP box in E2F1 is aligned with the PIP box in Cdt1 (Arias and 
Walter, 2006; Senga et al., 2006). Q, glutamine. h, hydrophobic amino acid. a, aromatic amino acid. x, any 
amino acid. The PIP mutant E2F1 constructs created for this study are indicated above the alignment (PIP-3A, 
PIP-7A, and PIP-7del). “A” and “-” indicate mutation to alanines and deletion, respectively. 
(B) Cell cycle profiles of S2 cells stably transfected to express GFP-E2F1WT under the Hsp70 promoter. Cells 
were heat-shocked for 30 min at 37˚C, and fixed at the indicated time points post heat shock.  
(C) Cell cycle profiles of S2 cells stably transfected to express GFP-E2F1 variants under the Hsp70 promoter. 
Cells were heat-shocked for 30 min at 37˚C, and fixed at 225 min post heat shock. 
(D) Quantification of S phase percentages. The experiment described in C was repeated three times (one of 
which is shown in C), and the percentages of S phase cells were calculated for all cells (unfilled) and GFP 
positive cells (filled in green). Average percentages are shown, and error bars indicate standard deviations. 
(B-D) The GFP positive gate was determined as 99.9% of non-heat-shocked transfected cells are excluded from 
the gate. 
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Based on the result of the time course experiment, we decided to use the time point 
of 225 min post heat shock for later analyses, because most of the S phase cells have 
degraded GFP-E2F1WT at this time point (Figure 3.2B). S2 cells were stably transfected with 
Hsp70-controlled GFP-E2F1 variants (WT, ΔCDK, L786Q, PIP-3A, PIP-7A and PIP-7del). 
These stable transfectants were heat shocked and fixed at 225 min post heat shock. As shown 
in Figure 3.2C, S phase-specific destruction was observed in the GFP-E2F1 WT, ΔCDK, and 
L786Q stable transfectants. In contrast, the PIP mutant E2F1s were not degraded during S 
phase. The experiment was repeated three times to confirm reproducibility and quantified in 
Figure 3.2D. Furthermore, when cells were stained for BrdU incorporation (S phase marker), 
a significant number of GFP-E2F1/BrdU double positive nuclei were observed specifically 
for the PIP mutants (Figure 3.3). These results clearly show that the PIP box of E2F1 is 
required for the S phase-specific destruction of E2F1 in S2 cells.  
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 Figure 3.3: The PIP mutant E2F1 accumulates in the nucleus during S phase 
S2 cells stably transfected to express GFP-E2F1 variants under the Hsp70 promoter were heat shocked for 30 
min at 37˚C, pulse-labeled with BrdU, and stained for BrdU incorporation (magenta). GFP fluorescence is 
shown in green. Wild type, ΔCDK mutant, and L786Q mutant E2F1 accumulate in the nucleus outside of S 
phase (green arrows) and degraded during S phase (magenta arrowheads). In contrast, PIP mutant E2F1s are 
stabilized and accumulated in the nucleus during S phase (white arrows).
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The destruction of E2F1 requires Cul4, Cdt2, PCNA, and DP 
The PIP box-dependent, S phase-specific destruction of Drosophila E2F1 led to the 
hypothesis that Drosophila E2F1 is degraded by the same pathway used for Cdt1 destruction, 
which involves the Cul4DDB1-Cdt2 ubiquitin ligase complex and PCNA (Arias and Walter, 
2006; Jin et al., 2006; Senga et al., 2006). To test this hypothesis, we knocked down Cul4, 
Ddb1, Cdt2 and Pcna in S2 cells by RNAi. We also knocked down the genes encoding the 
Cul1 ubiquitin ligase complex members (Cul1, Skp1, Slmb, Skp2, and Ago), because Cul1Slmb 
and Cul1Skp2 are suggested to be involved in the destruction of Drosophila E2F1 and human 
E2F1, respectively (Heriche et al., 2003; Marti et al., 1999). In addition, the knockdown of 
Rbf1 and Dp was tested, because they play central roles in the E2F/DP/RB pathway, and 
because it has been suggested that human E2F1 is protected from destruction by pRB 
(Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996).  
For the RNAi experiment, stable S2 transfectants of Hsp70-controled GFP-E2F1WT 
were incubated with dsRNAs for 2 days and tested for the S phase-specific destruction 
(Figure 3.4A). The successful knockdown of the RNAi-target genes was confirmed by RT-
PCR (Figure 3.4B) and Western blot analysis (Figure 3.4C). As shown in Figure 3.4A, RNAi 
against Cul4, Cdt2, and Pcna stabilized GFP-E2F1WT during S phase. In agreement with our 
PIP mutant data (Figure 3.2) and previous work on Cdt1 destruction (Arias and Walter, 2006; 
Jin et al., 2006; Senga et al., 2006), our RNAi data suggest that Drosophila E2F1 is degraded 
during S phase via E2F1’s binding to PCNA, which triggers the action of the Cul4-based 
ubiquitin ligase that contains Cdt2 as a substrate receptor.  
Surprisingly, the knockdown of Ddb1, which encodes the only known Cul4-
associated adapter protein, did not result in E2F1 stabilization (Figure 3.4A) even though the 
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RNAi successfully reduced Ddb1 transcript and DDB1 protein to very low levels (Figure 
3.4B and C). We reason that it is either because the Ddb1 knockdown was not sufficient, so 
that residual Ddb1 can still handle E2F1 destruction, or because there is another unidentified 
adaptor protein that can form a functional ubiquitin ligase complex with Cul4 and Cdt2. 
 Another unexpected finding was that the knockdown of Dp stabilized E2F1 during S 
phase (Figure 3.4A). Although the reason for this is currently unknown, the stabilization may 
be a direct consequence of the failure to form an E2F1/DP heterodimer, or an indirect effect 
of reduced E2F1-target gene transcription (discussed below).  
Rbf1 RNAi did not stabilize E2F1, consistent with the normal destruction of the 
RBF1-binding defective mutant E2F1L786Q (Figure 3.1C). From these results, we conclude 
that the S phase-specific destruction of E2F1 is independent of RBF1 in S2 cells. 
 No obvious stabilization of E2F1 was observed in S2 cells with RNAi against the 
components of the Cul1 ubiquitin ligase complex (Cul1, Skp1, Slmb, Skp2 and Ago). Cul1 
and Slmb RNAi may have slightly stabilized E2F1 during S phase, indicated by the slight 
increase in S phase percentages in the GFP positive population. This is consistent with a 
previous report that suggests the involvement of Cul1Slmb in E2F1 destruction (Heriche et al., 
2003). However, the data presented here suggests that Cul4Cdt2 and PCNA play more 
significant roles in E2F1 destruction than the Cul1-based ubiquitin ligases do.  
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 Figure 3.4: Knockdown of Cul4, Cdt2, PCNA, or DP stabilizes E2F1 during S phase in S2 cells 
(A) Cell cycle profiles of S2 cells stably transfected to express GFP-E2F1 under the Hsp70 promoter. Gene-
specific dsRNAs of indicated amounts were added to cell culture. After 2 days of incubation with dsRNAs, 
GFP-E2F1WT expression was induced by 30 min heat shock at 37˚C. Cells were fixed at 225 min post heat 
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shock. For the RNAi experiment, the GFP positive gate was determined as 99.97% (instead of 99.9%) of non-
heat-shocked transfected cells are excluded from the gate. 
(B) RT-PCR for the RNAi target genes. Mock templates without reverse transcriptase (RT-) were used to show 
the absence of genomic DNA contamination. rp49 is shown as an internal control. Note that the RNAi for Cul4, 
Ddb1, Cdt2 or Pcna does not affect the transcript levels of the other genes, suggesting that the effects of Cul4, 
Cdt2 and Pcna knockdown on E2F1 destruction are independent with each other.  
(C) Western blot of the RNAi target genes. α-tubulin was used as an internal control. 
 
E2F1 interacts with Cul4 and Cdt2  
To further examine the hypothesis that E2F1 is degraded through its binding to 
PCNA and to the Cul4 ubiquitin ligase complex, we employed a biochemical approach. myc-
tagged E2F1 WT or PIP-3A were co-expressed with HA-tagged Cul4, Cdt2, or DP in S2 
cells. Transfected cells were lysed and subjected to immunoprecipitation (IP) using an anti-
myc antibody. The IPs and inputs were then analyzed by western blot using anti-myc and 
anti-HA antibodies (Figure 3.5). HA-Cul4 and HA-Cdt2 were co-immunoprecipitated with 
myc-E2F1PIP-3A, as well as with myc-E2F1WT, suggesting that the interaction between E2F1 
and the Cul4Cdt2 complex is independent of E2F1’s PIP box. These HA-constructs were not 
immunoprecipitated in the absence of myc-E2F1 co-expression, eliminating the possibility of 
non-specific interaction between the HA-constructs and anti-myc-conjugated beads. 
Interestingly, the expression levels of myc-E2F1WT and myc-E2F1PIP-3A were 
severely reduced when HA-DP was co-transfected. Also, the expression of HA-DP was 
reduced with the co-expression of myc-E2F1s.  In spite of this, a significant amount of DP 
was co-immunoprecipitated with both myc-E2F1WT and myc-E2F1PIP-3A. Although the reason 
E2F1 expression levels are decreased by DP co-expression is currently unknown, this is 
consistent with the stabilization of E2F1 caused by DP knockdown (Figure 3.4A). 
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 Figure 3.5: E2F1 interacts with Cul4 and Cdt2 
Co-immunoprecipitation/Western blot showing interactions between myc-E2F1 (WT and PIP-3A) and HA-
constructs (Cul4, Cdt2, and DP). S2 cells were transiently transfected to express myc-E2F1 and/or HA-
constructs under the control of the Actin promoter. Transfected cells were lysed and immunoprecipitated for 
myc. Immunoprecipitates and 2.5% inputs were subjected to Western blot analysis using anti-HA or anti-myc 
antibodies. DP was used as a positive control as a known E2F1 binding protein. Asterisks indicate non-specific 
bands. 
 
The PIP mutation stabilizes E2F1 during S phase in vivo 
The S2 cell data suggests that E2F1 is degraded in a similar manner to Cdt1. To test if 
E2F1 is also degraded by the same mechanism in vivo, we created transgenic flies bearing 
UAS-GFP-E2f1 WT, PIP-3A, PIP-7A or PIP-7del. These UAS flies were crossed to 
engrailed (en)-Gal4 driver flies to induce expression. In the embryo, GFP-E2F1WT was 
degraded in the epidermal cells undergoing S phase of cycle 17 (Figure 3.6, arrows). In 
contrast, GFP-E2F1PIP-3A was stabilized in these S phase cells (Figure 3.6, arrowheads). 
Similar stabilization was also seen in GFP-E2F1PIP-7A and GFP-E2F1PIP-7del (data not shown). 
The result shows that E2F1 is degraded in the PIP box-dependent manner in vivo, as in S2 
cells. 
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 Figure 3.6. Mutations in the PIP box stabilize E2F1 during S phase in vivo 
Embryos were pulse-labeled with BrdU for 5 min and stained for GFP (green), BrdU (red) together with 
phosphotyrosine (P-Tyr, blue) to visualize cell-cell boundaries. Embryos were collected from en>E2F1WT (en-
Gal4 mothers crossed to UAS-GFP-E2f1WT males) and en > E2F1PIP-3A. Arrows and arrowheads indicate a group 
of cells in the first and second thoracic segments undergoing S phase of cycle 17 (S17). Note that GFP-E2F1 is 
degraded in S17 (arrows), whereas GFP-E2F1PIP-3A is stabilized (arrowheads). 
 
GFP-E2F1WT and GFP-E2F1PIP are functional as a transcription factor in vivo 
Given that PIP mutant E2F1 is stabilized during S phase, we then examined the effect 
of overexpressing GFP-E2F1WT or GFP-E2F1PIP on the expression of E2F1-taget genes. To 
visualize E2F1’s transcriptional activity, we stained embryos for transcripts of RnrS, a well-
characterized E2F1-target gene (Dimova et al., 2003; Duronio and O'Farrell, 1994). Using 
paired (prd)-Gal4 driver, GFP-E2F1WT or GFP-E2F1PIP was overexpressed in seven stripes 
in the embryo. In these stripes, ectopic RnrS was induced by GFP-E2F1WT or GFP-E2F1PIP-3A 
(Figure 3.7A, top row). GFP-E2F1PIP-3A induced slightly higher levels of RnrS than GFP-
E2F1WT does, when overexpressed with prd-Gal4. This tendency was more obvious when 
armadillo (arm)-Gal4 was used. arm-Gal4 induces ubiquitous expression of UAS-controlled 
genes throughout the embryo. The arm-Gal4-driven expression of GFP-E2F1WT and GFP-
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E2F1PIP-3A induced ectopic RnrS mainly in the midgut, a tissue that undergoes an endocycle 
(Figure 3.7A, middle and bottom rows). In the midgut of a wild type embryo at stage 14, 
RnrS expression is prominent in the central midgut, where cells are undergoing synchronous 
S phase (Figure 3.7A and 6B, wild type). The overexpression of GFP-E2F1WT or GFP-
E2F1PIP-3A induced ectopic RnrS in the anterior and posterior midgut. Notably, the induction 
levels of RnrS were significantly higher in GFP-E2F1PIP-3A-expressing embryos than that of 
GFP-E2F1WT-expressing ones. This tendency was consistently observed in four independent 
lines of UAS-GFP-E2f1WT and UAS-GFP-E2f1PIP-3A each (data not shown). Furthermore, one 
line from UAS-GFP-E2f1PIP-7A and UAS-GFP-E2f1PIP-7del each was tested, and we observed 
similar levels of RnrS induction to UAS-GFP-E2f1PIP-3A (data not shown). These results 
suggest that GFP-E2F1WT and GFP-E2F1PIP are functional as a transcription factor in vivo, 
and that the stabilization of E2F1 by the PIP mutation enhances the ectopic induction of 
E2F1 target genes. 
However, in the epidermis of late stage embryos (stage 12-14), RnrS transcripts 
were normally downregulated even with GFP-E2F1WT or GFP-E2F1PIP-3A (Figure 3.7A for 
arm-Gal4 and data not shown for prd-Gal4). We attribute the absence of increased RnrS in 
late embryogenesis to the developmentally-regulated activation of RBF1 (Du and Dyson, 
1999) and the limited amount of endogenous DP. Indeed, it has been shown that the 
overexpression of E2F1 by itself will not induce RnrS in late embryogenesis, unless DP is co-
expressed (Duronio et al., 1996). In addition, there may be unidentified downregulation 
mechanisms which contribute to the absence of ectopic RnrS induction in the epidermis. 
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 Figure 3.7: GFP-E2F1WT and GFP-E2F1PIP are functional as a transcription factor 
(A) Embryos were stained for RnrS transcripts by in situ hybridization. Embryos were collected from wild type 
(w1118), prd>E2F1WT (prd-Gal4 mothers crossed to UAS-GFP-E2f1 males), prd>E2F1PIP-3A, arm>E2F1WT, or 
arm>E2F1PIP-3A. 
Stage 10 embryos (top row) and stage 14 embryos (middle row, lateral views; bottom row; sagital views) are 
shown. Arrowheads show the induction of RnrS in cells where the prd promoter is activated. 
(B) Embryos were pulse-labeled with BrdU and stained for BrdU incorporation. Embryos were collected from 
wild type, arm>E2F1WT, or arm>E2F1PIP-3A. Expression of GFP-E2F1WT and GFP-E2F1PIP-3A was confirmed by 
GFP staining (not shown). 
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The progression of endocycles in the gut is disturbed by the overexpression of GFP-
E2F1WT or GFP-E2F1PIP 
We next asked if the overexpression of GFP-E2F1WT or GFP-E2F1PIP leads to cell 
cycle defects. To address this question, we examined embryos stained for BrdU incorporation 
and for phospho-histone H3 (PH3), a mitosis marker. However, at least until stage 14, we did 
not detect ectopic S phase or mitosis in the epidermis overexpressing GFP-E2F1WT or GFP-
E2F1PIP with prd-Gal4 or arm-Gal4 (data not shown). Although we did not detect defects in 
the mitotic cycle of the embryonic epidermal cells, the endocycle in the midgut was disturbed 
when GFP-E2F1WT or GFP-E2F1PIP was overexpressed with arm-Gal4 (Figure 3.7B and data 
not shown for PIP-7A and PIP-7del). This is consistent with the ectopic RnrS induction 
caused by GFP-E2F1WT or GFP-E2F1PIP (Figure 3.7A). In the embryo overexpressing GFP-
E2F1WT or GFP-E2F1PIP, the S phase pattern was overall normal at stage 13 (Figure 3.7B). 
However, a synchronous gap phase that is seen in the anterior and posterior midgut of stage 
14 and 15 wild type embryos was absent in the embryos overexpressing GFP-E2F1WT or 
GFP-E2F1PIP-3A. This result implies that proper endocycle progression requires the 
downregulation of E2F1 activity, as further examined in the larval salivary gland, another 
endocycling tissue (see discussion). 
 
Stabilization of E2F1 during S phase activates an apoptotic pathway 
Since we did not detect cell cycle defects in mitotic cycles of embryogenesis, we 
focused on the wing disc of 3rd instar larva. The cells in the wing disc undergo G1-S-G2-M 
mitotic cell cycles and will have been exposed to GFP-E2F1 overexpression for a longer time 
than embryos. We overexpressed GFP-E2F1WT or GFP-E2F1PIP-3A using en-Gal4, which 
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induces expression only in the posterior half of the wing disc. This allows us to compare the 
transgene-overexpressing posterior half and the non-expressing anterior half within one disc.  
To ask whether GFP-E2F1WT or GFP-E2F1PIP induces ectopic mitosis index, we 
stained discs for PH3. We observed slight increase in PH3 positive nuclei in GFP-E2F1PIP-3A-
overexpressing cells (data not shown). This induction of mitosis may be underestimated since 
the overexpression of GFP-E2F1PIP-3A induced massive apoptosis, as shown by the induction 
of cleaved Caspase-3 (apoptosis marker) (Figure 3.8A). Interestingly, the overexpression of 
GFP-E2F1WT did not induce apoptosis, suggesting that the apoptosis is caused by the 
stabilization of E2F1 during S phase.  
Furthermore, consistent with increased apoptosis, the morphology of the adult wing 
was disturbed in the posterior half of GFP-E2F1PIP-3A-overexpressing adult flies, in contrast 
to normal morphology of GFP-E2F1WT-overexpressing wings (Figure 3.8C). The severity of 
wing phenotype varies from mild (small size of the posterior wing, Figure 3.8C, third panel) 
to severe (shrunken wing morphology often with a blister in the posterior side, Figure 3.8C, 
bottom panel). This phenotype appears dependent on the environment; flies from crowded 
vials tend to have less severe phenotype. In this case, we often observed normal wing 
morphology even with the overexpression of GFP-E2F1PIP-3A (data not shown). Nevertheless, 
these findings suggest that the S phase-specific degradation of E2F1 is required for the 
normal development of fly tissues, most likely because the ectopic expression of E2F1 during 
S phase activates apoptotic pathways. 
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 Figure 3.8: Stabilization of E2F1 during S phase induces apoptosis 
(A) Wing discs from 3rd instar larvae were stained for cleaved Caspase-3 (red) and DNA (DAPI). Transgene 
expression is shown by GFP fluorescence (green). Anterior: top right. Posterior: bottom left. Note that Casp-3-
positive cells are piled on the surface of the disc, as shown in the DAPI staining. These cells contain small and 
condensed nuclei, which is a characteristic of apoptotic cells.  
(B) Wing discs dissected from 3rd instar larvae of en>GFP (en-Gal4 mothers crossed to UAS-GFP males), 
en>E2F1WT, or en>E2F1PIP-3A were lysed, and 5 μg of total protein was subjected to Western blot analysis. α-
tubulin was blotted as a loading control. 
(C) Wings of adult flies born from en>GFP,  en>E2F1WT, or en>E2F1PIP-3A. 
The morphology of the posterior side of the wing is disturbed in E2F1PIP-3A-expressing flies. A wing with a 
moderate phenotype (left bottom panel) and severe phenotype (right bottom panel) are shown. 
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Discussion 
In this chapter, we showed that Drosophila E2F1 is degraded during S phase in a 
PCNA-, Cul4-, and Cdt2-dependent manner, which resembles the destruction mechanism of 
Cdt1. (Arias and Walter, 2006; Jin et al., 2006; Senga et al., 2006). It is suggested that the 
interaction between Cdt1 and PCNA triggers the ubiquitination of Cdt1 by Cul4DDB1-Cdt2. 
Since PCNA forms homotrimers around the DNA strand during S phase (Moldovan et al., 
2007), this homotrimer may provide an S phase-specific binding site for Cdt1. Our data 
shown here suggests that a common mechanism is used for the destruction of Drosophila 
E2F1.  
 
Normal E2F1 destruction in DDB1-depleted cells 
Given that E2F1 is stabilized by RNAi against Pcna, Cul4 or Cdt2, we were surprised 
that Ddb1 RNAi did not stabilize E2F1 (Figure 3.4). DDB1 is the major adapter protein that 
mediates the assembly of Cul4 and Cul4-associated substrate receptors named DCAFs 
including Cdt2 into an active ubiquitin ligase (Jin et al., 2006). Indeed, DDB1 is required for 
the destruction of Cdt1 (Arias and Walter, 2006; Jin et al., 2006; Senga et al., 2006). The 
reason for the absence of E2F1 stabilization in DDB1-depleted cells is currently unknown. 
Although our RNAi depleted Ddb1 mRNA and DDB1 protein almost to background levels 
(Figure 3.4B, C), it is possible that a very little amount of residual DDB1 is sufficient to 
handle E2F1 destruction. Alternatively, there may be other Cul4- and DCAF-associated 
adapter proteins that have not been identified.  
 
DP-dependent, CDK- and RBF1-independent destruction of E2F1 
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Unexpectedly, the RNAi against Dp stabilized E2F1 during S phase (Figure 3.4A), 
and the co-expression of DP destabilized E2F1 (Figure 3.5). DP is a binding partner of E2F1, 
and E2F1/DP heterodimerization enhances their ability to bind DNA (Dynlacht et al., 1994). 
One possibility is that E2F1/DP induces transcription of genes involved in E2F1 destruction 
(e.g. Cdt2), so that DP indirectly enhances the destruction of E2F1. Another possibility is that 
the destruction of E2F1 directly requires DP-binding. In this case, E2F1’s DNA-binding 
activity, which is facilitated by E2F1/DP dimerization, may be required for E2F1 destruction. 
However, this hypothesis is at a glance in conflict with the data that the 1-230, 93-184, and 
139-230 fragments of E2F1 can be degraded during S phase, even though these N-terminal 
fragments do not contain either the DNA-binding domain or the DP-dimerization domain 
(Figure 3.1). This conflict can be formally reconciled by introducing a hypothetical signal 
sequence which inhibits E2F1 destruction. The data presented here can be explained if this 
hypothetical signal resides in the region C-terminal to 231 (231-805), and can be inactivated 
by DP-binding. In this model, the inhibitory signal in the full length E2F1 is suppressed by 
DP-binding, allowing the PIP-dependent destruction of E2F1. On the other hand, the 1-230 
fragment can be degraded whether DP is present or not, since it does not contain the 
inhibitory signal. 
 In contrast, mutations in the consensus CDK phosphorylation sites did not result in 
significant stabilization of E2F1 (Figure 3.1, 3.2, and 3.3). Thus, the direct phosphorylation 
of E2F1 by CDK does not appear to be the major mechanism involved in E2F1 destruction. 
However, since CycE/CDK2 induces S phase entry and E2F1 is degraded in an S phase-
dependent manner, CycE/CDK2 indirectly downregulates E2F1 via the induction of S phase. 
Previously, Reis et al. showed that increased CycE/CDK2 activity in the wing disc results in 
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the downregulation of E2f1 transcripts (Reis and Edgar, 2004). Therefore, CycE/CDK2 can 
downregulate E2F1 levels at least in two ways: the transcriptional repression of the E2f1 
gene, and the induction of S phase entry, which in turn induces E2F1 destruction.  
 Previous studies have shown that human E2F1 can be protected by the co-expression 
of pRB (Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996). 
However, in our experiments a mutation in the RBF1-binding site of E2F1 (E2F1L786Q) and 
the knockdown of Rbf1 did not affect the destruction of E2F1 (Figure 3.1, 3.2, 3.3, and 3.4). 
Moreover, the overexpression of RBF1280, an active form of RBF1 that has mutations in four 
CDK phosphorylation sites, did not stabilize E2F1 in the embryo (data not shown). This 
RBF1-independent destruction of Drosophila E2F1 may simply be explained by the fact that 
Drosophila E2F1 and human E2F1 are degraded by different machineries (Cul4 vs. Cul1). It 
is possible that the degradation of human E2F1 by the Cul1SKP2 complex (and possibly by 
other ubiquitin ligase complexes) requires the access to E2F1’s C-terminus, which can be 
blocked by the binding of pRB to E2F1’s C-terminus. 
 
E2F1-induced apoptosis 
A large body of evidence suggests that activator E2Fs are positive regulators of 
apoptosis  (Iaquinta and Lees, 2007). However, E2F-induced apoptosis is highly context-
dependent, and little is known about the mechanism that underlies this context-dependency 
(Hallstrom et al., 2008; Iaquinta and Lees, 2007; Moon et al., 2006; Moon et al., 2005). Our 
data presented here shows that the expression of PIP mutant E2F1 induces massive apoptosis, 
whereas wild type E2F1 do not induce any apoptosis (Figure 3.8). This suggests that the 
stabilization of E2F1 during S phase activates apoptotic pathways. An interesting hypothesis 
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is that cells possess an S phase-specific sensor to detect ectopic E2F1 activity. When E2F 
activity remains high in S phase, cells may detect it and activate apoptotic pathways. 
Otherwise, elevated E2F1 activity may cause overproliferation. Moreover, failure to 
downregulate E2F1 activity during S phase may cause unwanted DNA re-replication since 
E2F1 can induce origin licensing factors such as Cdt1Dup and Cdc6. 
Alternatively, E2F1-induced re-replication may be the cause of apoptosis. Although 
the overexpression of E2F1WT or E2F1PIP performed here appeared to have no detectable 
effect on mitotic cell cycles, it is possible that cells are so sensitive to re-replication that we 
could not detect obvious cell cycle defect before cells die by apoptosis. Future experiments 
will elucidate the mechanism underlying S phase-specific, E2F-induced apoptosis. 
 
Significance of E2F1 destruction in endocycles 
In the embryonic gut, E2F1 overexpression induced ectopic expression of RnrS, an 
E2F1-target gene. As a probable consequence, the synchronous cell cycle progression of the 
endocycle was disrupted (Figure 3.7). We did not observe obvious differences between the 
cell cycle phenotypes caused by GFP-E2F1WT and GFP-E2F1PIP, at least until stage 15. This 
may be due to the high sensitivity of embryonic gut cells to increased E2F1 levels. However, 
a critical difference has been observed between GFP-E2F1WT and GFP-E2F1PIP when 
overexpressed in the larval salivary gland (Figure 3.9). The cells in the salivary gland 
undergo asynchronous endocycles to achieve very high levels of polyploidy (~2048C) (Edgar 
and Orr-Weaver, 2001), making the larval salivary gland an excellent experimental model to 
study endocycle regulation. Previous studies have shown that the oscillation of CycE/CDK2 
activity is required for endocycle progression in this tissue (Follette et al., 1998; Weiss et al., 
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1998). Consistently, low CDK activity during early G1 is thought to allow the assembly of 
the pre-replication complex, which is required for the origin firing in the following S phase 
(Blow and Dutta, 2005). However, the mechanism that generates this oscillation of 
CycE/CDK2 has not been fully understood. The data presented here provides a model for the 
regulation of an endocycle; E2F1 induces CycE expression, which induces S phase entry. 
During S phase E2F1 is downregulated by proteolysis, resulting in CycE downregulation. 
This simple regulatory system composed of E2F1, CycE/CDK2, and DNA replication may 
be the central mechanism that regulates endocycles in this tissue and possibly in other tissues 
(Kim et al. manuscript in preparation).  
 
Figure 3.9: Stabilization of E2F1 in the larval salivary gland arrests the cell cycle 
GFP-E2F1WT or GFP-E2F1PIP-3A (green) was expressed in the salivary gland with ptc-Gal4 driver. Salivary 
glands were dissected from 3rd instar larvae, pulse-labeled with BrdU (red), and stained with DAPI (blue). Note 
that GFP-E2FWT is degraded in BrdU positive nuclei (top panels). In contrast, GFP-E2F1PIP-3A-expressing 
salivary glands show reduced BrdU incorporation, resulting in decreased polyploidy and small size of the tissue. 
(Courtesy of Dr. Bruce A. Edgar) 
 
Taken together, our data indicate that E2F1 degradation is dependent on DNA 
replication and requires a Cul4-based ubiquitin ligase. This provides a model of negative 
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feedback mechanism where E2F1 induces DNA replication, which in turn downregulates 
E2F1. This negative feedback is required for preventing apoptosis in a mitotic cycle (larval 
wing disc) and for the cell cycle progression of an endocycle (larval salivary gland). In 
addition, the E2F1PIP mutants created in this study will provide a useful tool for future 
experiments. It is also interesting to investigate whether the destruction of activator E2Fs is 
required for normal cell cycle progression in other species.  
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CHAPTER IV 
 
E2F1-INDEPENDENT REGULATION OF RNRS TRANSCRIPTION DURING EARLY 
EMBRYOGENESIS 
 
 
Preface  
 This chapter describes a project on early expression of the E2F1-target gene RnrS that I 
initiated and that will be continued by others in the lab. I performed the majority of 
experiments shown in this chapter. Pam Gasdaska, a research technician in the lab, molecularly 
mapped the deleted regions of Df(3R)sr16 and sr461 mutants. (Figure 4.4) She also examined 
the expression of CG14317 transcripts (data not shown).  
Abstract 
 During Drosophila embryogenesis, DNA replication-related, E2F1-target genes are 
expressed specifically in cells that are actively replicating DNA. It has been assumed that the 
expression of these genes is regulated mainly by E2F1. However, here I describe a genomic 
locus that is required for the early zygotic expression of RnrS, a gene well-characterized as 
an E2F1-target gene. A deletion of the locus does not affect E2F1 expression, suggesting an 
E2F1-independent mechanism of early zygotic RnrS expression. Using an overlapping set of 
deletions in the region we identified 19 candidate genes for the RnrS phenotype.  
 
Introduction 
 During the early embryogenesis of Drosophila, E2F1-target genes such as RnrS, Pcna, 
CycE, and DNA polymerase alpha are expressed continuously during the G2-regulated, post-
blastoderm cell cycles, which lack G1 phase. This expression is thought to facilitate the rapid 
cell cycle during early embryogenesis. Although this expression pattern of these E2F1-target 
genes has been described in detail (Duronio and O'Farrell, 1994; Lee and Orr-Weaver, 2003), 
the responsible mechanisms remain to be understood.  
As shown in Figure 4.1, embryos contain maternal supplies of these transcripts at the 
beginning of embryogenesis (Figure 4.1, stage 1). These maternal supplies are cleared from 
the embryo by cycle 14 (Figure 4.1, stage 5). For the rest of embryogenesis, the transcripts of 
E2F1-target genes are transcribed from zygotic loci (Figure 4.1, stage 6-14).  
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 Figure 4.1: The expression pattern of RnrS transcripts during Drosophila embryogenesis 
Wild type embryos were stained for RnrS transcripts by in situ hybridization. Stages are determined by the 
morphology of the embryo and the staining pattern of RnrS. 
 
In E2f1 zygotic mutant embryos, the zygotic transcription of E2F1-target genes is 
severely reduced in late embryogenesis (late stage 11~) (Duronio et al., 1995). However, 
these transcripts are expressed at normal levels during the early embryogenesis (stage 6-11) 
of E2f1 mutants (Figure 2.5) (Duronio et al., 1995). One possible explanation is that maternal 
E2F1 protein is sufficient to induce early expression of E2F1-target genes even in the 
absence of zygotic E2F1. Indeed, residual maternal E2F1 protein can be observed in E2f1 
zygotic mutants until it is degraded during S phase of cycle 15 (stage 8-9) (Figure 2.5). 
Although the residual E2F1 protein is very little, it may be sufficient to induce the initial 
transcription of E2F1-target genes. Alternatively, the early transcription of E2F1-target genes 
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(i.e. stages 6-10) may be independent of E2F1 and regulated by other mechanisms. E2F1-
independent regulation of E2F1-target genes may appear counterintuitive because these 
E2F1-target genes are all very sensitive to E2F1 levels, which provides a model whereby cell 
cycle genes are coordinately expressed in a timely manner by one key factor (E2F1). 
However, in a screening experiment, I found a genomic locus that is required for the early 
zygotic transcription of RnrS. This finding raises the possibility that the early expression of 
RnrS is independent of E2F1. 
 
Materials and Methods 
Drosophila strains 
 Df(3R)ED5780, Df(3R)Exel6177, Df(3R)Exel6178, Df(3R)DG2, Df(3R)DG4, 
Df(3R)P14, Df(3R)sr16, Df(3R)LK19-1, Df(3R)Cha7, cpoBG02810, cpo01432, DNaseIIlo, 
DNaseIIB571, CG7785f06154, htld07110, sr461, sr155, and sr03999  were obtained from the 
Bloomington Stock Center. 
 
RNA in situ hybridization and immunostaining 
In situ hybridization and immunostaining was performed as described (Shibutani et 
al., 2007). Embryos were dechorionated with 50% bleach, fixed in a 1:1 mixture of 4% 
formaldehyde in PBS/heptane for 25 min at room temperature, and devitellinized with 
methanol. Embryos were stored in methanol at -20˚C. A digoxigenin-labeled RnrS probe was 
synthesized by transcribing antisense RNA from a full length RnrS cDNA (DGC collection 
clone LD41588, obtained from Open Biosystems). For the E2F1/RnrS/phosphotyrosine triple 
staining, the TSA Fluorescence System (Perkin Elmer) was used for detection of E2F1 and 
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RnrS. Antibodies used are: rabbit anti-E2F1 (1:500, gift from Dr. Maki Asano), goat anti-
rabbit-biotin (1:1000, Chemicon), mouse anti-phosphotyrosine (1:1000, Upstate), and donkey 
anti-mouse-Cy5 (1:500, Jackson). Stained embryos were mounted with Fluoromount-G 
(Southern Biotech) and visualized with a Nikon Eclipse E800 microscope or a Zeiss LSM 
510 scanning confocal microscope. Images were consistently modified with Photoshop® CS2 
9.0 (Adobe) 
 
Results 
I performed a screening experiment using Drosophila deficiency mutants with the 
intention of identifying a protein phosphatase 1 (PP1) subunit required for normal regulation 
of E2F1-target genes during embryogenesis. We performed the screening based on the 
hypothesis that RBF1 is activated by a PP1 complex during late embryogenesis, resulting in 
the suppression of E2F1-target genes. This initial hypothesis was disproved by Lisa Swanhart, 
a former graduate student in the lab who showed that PP1 is not required for the suppression 
of E2F1-target genes during embryogenesis (Swanhart et al 2007). Nevertheless, in the 
screening I found a deficiency mutant that shows decreased RnrS transcription during early 
embryogenesis (Figure 4.2, Df(3R)DG2). In this mutant, RnrS transcripts were severely 
reduced during early embryogenesis (stage 6-11). Interestingly, RnrS expression in the 
mutant was normal in the gut and central nervous system in late embryogenesis (Figure 4.2). 
In addition, when the mutant embryos were stained for transcripts of other E2F1-target genes 
(RnrL, CycE, Pcna, Mcm2, and dup), I observed normal levels of these transcripts (data not 
shown). In the mutant, neither the RnrS gene nor the E2f1 gene is deleted. In addition, E2F1 
protein levels were normal (Figure 4.3), suggesting that E2F1 is not sufficient to induce early 
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zygotic RnrS. Taken together, the early zygotic expression of RnrS was severely reduced in 
the mutant in an E2F1-independent manner, and this phenotype is specific for RnrS 
expression among E2F1-target genes tested.  
 
Figure 4.2: RnrS phenotypes in deficiency mutants 
Embryos were stained for RnrS. In each row, the left panel is a sibling control of the homozygous mutant in the 
right panel. Top four rows show stage 10 embryos, and the bottom row shows stage 12 embryos. 
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 Figure 4.3: E2F1 expression in the mutant embryo 
Embryos were stained for E2F1 (green), RnrS (red), and phosphotyrosine (P-Tyr, blue). A embryo homozygous 
for Df(3R)sr16 (bottom panels) and a sibling control embryo (top panels) are shown. Note that the expression of 
E2F1 is not affected in the mutant. Scare bar: 50μm. 
 
To narrow down the region responsible for the phenotype, we examined embryos of 
various other deficiency mutants. The result is summarized in Figure 4.4. Of the deficiency 
mutants tested, the DG2, P14, sr16, and DG4 deficiency mutants showed decreased RnrS 
expression, whereas the others (ED5780, Exel6117, LK19-1, Exel6178, and Cha7) did not 
show the phenotype. The Exel6177 and Exel6178 deficiency mutants, both of which did not 
show the RnrS phenotype, are annotated with the exact break points. The Exel6177 
deficiency eliminates CG14318, but not the next gene CG7713. The Exel6178 deficiency 
eliminates the whole open reading frame of CG7215 and the translation start site of CG7217, 
but does not eliminate the next gene, Cbp20. Thus, we can accurately narrow down the 
region of interest to the 23 genes from CG7713 (locus = 90C5) to Cbp20 (90E7). From these 
23 genes, we could further eliminate 4 genes (CG14316 to Cbp20) by PCR-based mapping of 
the sr16 deficiency (data not shown), leaving 19 genes (CG7713 to stripe (sr)) as possible 
candidate genes. Furthermore, the DG4 deficiency, which shows the RnrS phenotype, has 
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been cytologically mapped to 90D2-4/90F3-6. From this, we inferred that 7 genes from 
couch potato (cpo) (90D1-6) to sr (90E2-4) are the most likely candidate genes for the RnrS 
phenotype (Figure 4.4).  
Figure 4.4: The mapping of the locus showing the RnrS phenotype 
Chromosome deficiencies are shown in black solid bars with the breakpoint locus at each end of the bar. The 
gene name in the parenthesis below the breakpoint locus indicates the gene deleted by the deficiency. 
Deficiencies with molecularly-mapped breakpoints are shown with black ends, whereas ones with 
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cytologically-mapped breakpoints (mapped by chromatin banding pattern of polytene chromosomes in the 
salivary gland) are shown with gray ends. Note that Df(3R)sr16 (previously mapped to 90D1-2/90E1-2) and 
sr461 are re-mapped by PCR to 90C2-4/90E2-4. 
 
Among these 7 most likely candidate genes, mutant flies were available for cpo, 
DNase II, CC7785, htl, and sr (homozygous lethal: cpoBG02810, cpo01432, htld07110, sr461, sr155, 
and sr03999, homozygous viable: DNaseIIlo, DNaseIIB571, and CG7785f06154). No mutants were 
available for CC7794 and CG14317. We examined RnrS transcription of these mutant 
embryos, and found that one sr mutant allele, sr461, shows the RnrS phenotype (Figure 4.2), 
whereas the other sr alleles do not. However, later we found that the sr461 allele is a deletion 
mutant which deletes at least 19 genes (from CG14318 to CG14317, data not shown). This is 
consistent with our complementation tests, where sr461 partially complemented two other sr 
alleles: sr03999 (P-element insertion) and sr155 (point mutation), and failed to complement with 
cpo and htl (Table 4.1). Moreover, sr03999 and sr155 did not show the RnrS phenotype, 
suggesting that sr is not responsible for the RnrS phenotype. 
 
Table 4.1 The complementation test of the mutants in the suspected locus for the RnrS phenotype 
yes: complemented, no: failed to complement, N/D: not determined. Asterisks indicate partial complementation. 
*: 70/419 (non-balanced/balanced), **: 89/439, ***: 27/587. 
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Discussion 
 Our search for a PP1 subunit that regulates RBF1 activity during embryogenesis 
revealed an unexpected phenotype: decreased zygotic RnrS transcription during early 
embryogenesis. This was surprising for us, because RnrS is a well-characterized E2F1-target 
gene (Dimova et al., 2003; Duronio and O'Farrell, 1994), and it is widely accepted that RnrS 
and other E2F1-target genes are mainly regulated by E2F1. The mutants that show the RnrS 
phenotype do not bear mutations in the E2f1 gene, and E2F1 protein levels were normal in 
the mutants, leading us to hypothesize an E2F1-independent regulation of “E2F1-target 
genes” during early embryogenesis. Interestingly, in the mutants, other E2F1-target genes are 
expressed in a normal pattern throughout embryogenesis. Moreover, the transcription of RnrS 
is decreased in the mutants only during early embryogenesis. These findings suggest a gene-
specific, stage-specific regulation of RnrS expression.  
 What then is the mechanism underlying this RnrS phenotype? Formally, 19 genes 
from CG7731 to sr are candidate genes based on molecular mapping (see results). Of these 
19 genes, 7 genes including cpo, DNase II, CG7785, CG7794, htl, CG14317, and sr were the 
most likely candidates based on a cytologically-mapped deficiency (DG4). Among these 
most suspected genes, mutant flies of cpo, DNase II, CC7785, htl, and sr were available and 
none of these mutants showed the RnrS phenotype. Therefore, 2 genes (CG7794 and 
CG14317) remain as the most likely candidates so far. The protein BLAST search using 
CG7794 and CG14317 showed homology to α-tubulin, and no conserved mammalian 
orthologs, respectively. Interestingly, the BioGRID yeast two hybrid database 
(http://www.thebiogrid.org) shows the interaction of CG14317 with cell cycle regulators 
(CDK2, Cul2, SkpA (Skp1), SkpB, and SkpC) and with transcription factors (TATA-binding 
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protein associated factor 11 and Tramtrack69) (Giot et al., 2003; Stanyon et al., 2004). 
Furthermore, an in situ hybridization experiment showed that the expression timing of 
CG14317 correlates well with the onset of the RnrS phenotype; it is ubiquitously expressed 
only during early embryogenesis (data not shown).  
Although the RnrS phenotype discovered here suggests that E2F1 is not sufficient for 
the early zygotic transcription of RnrS, it does not exclude the possibility that E2F1 is 
required for the early zygotic transcription of E2F1-target genes. We cannot test this idea 
simply by using zygotic E2f1 mutant embryos because maternal E2F1 protein remains until 
stages when the early zygotic transcription starts (Figure 2.5). Embryos of maternal and 
zygotic E2f1 null mutant die during very early embryogenesis, making it impossible to 
determine the RnrS phenotype of these mutant embryos. 
Although we are currently investigating the possible E2F1-independent regulation 
during early embryogenesis, it should be noted that it is also formally possible that the RnrS 
phenotype is caused by a slight decrease in E2F1 activity. In this scenario, the mutations 
eliminate a gene that supports E2F1 activity during early embryogenesis. RnrS may be the 
only E2F1-target gene that is sensitive to the slight reduction of E2F1 activity, and therefore 
the only gene whose expression is affected. These possibilities will be further examined in 
future experiments in our laboratory. 
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CHAPTER V 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
 
The E2F/DP/RB pathway plays a central role in cell cycle regulation. However, the 
regulation of the pathway in vivo has yet to be fully understood. In this thesis, I started with 
the question of how E2F1 activity is downregulated during Drosophila embryogenesis, and 
discovered a developmentally-regulated onset of E2F1 destruction (Chapter II). In the course 
of the study, we found that the destruction of E2F1 occurs specifically during early S phase. 
Our attempt to understand this S phase-specific E2F1 destruction led to the discovery of the 
mechanism; E2F1 is degraded during S phase through its interaction with PCNA, Cul4, Cdt2, 
and DP. We further showed that the stabilization of E2F1 during S phase induces apoptosis 
(Chapter III). In addition, we identified a genomic locus that is required for the early zygotic 
transcription of RnrS, an E2F1-target gene (Chapter IV). This finding raised the possibility of 
an E2F1-independent mechanism that is necessary for the early zygotic transcription of 
“E2F1-target genes”. 
 
E2F1 destruction as a mechanism of E2F1-target gene downregulation during 
Drosophila embryogenesis 
 During Drosophila embryogenesis, E2F1-target genes are expressed specifically in 
cells that are actively cycling (Duronio and O'Farrell, 1994). One way to explain the 
correlation between E2F1-target gene expression and active cell cycle is that E2F1 activity is 
developmentally regulated and, as a consequence, the cell cycle follows. This cause-
consequence relationship is supported by the fact that E2f1 mutant embryos show impaired 
DNA replication when the maternal supply of E2F1 is depleted (Duronio et al., 1995).  
Then, what is the mechanism that regulates the spatiotemporal pattern of E2F1-target 
gene expression during embryogenesis? In Chapter II, we showed RBF1-independent, Dap-
independent downregulation of E2F1-target genes during early embryogenesis. This finding 
was unexpected for us, since RBF1 and Dap are major inhibitors of the potential E2F1-
CycE/CDK2 positive feedback loop. In the search for an alternative mechanism of E2F1 
downregulation, we found developmentally-regulated E2F1 destruction (Figure 2.3), leading 
to the hypothesis that the initial downregulation of E2F1-target genes is caused by this onset 
of E2F1 destruction. Although we successfully identified the mechanism of E2F1 destruction 
(Chapter III), the developmental signal regulating the onset of E2F1 destruction is currently 
unknown. The signal may be the downregulation of a maternal factor(s) that protects E2F1 
from destruction and/or the induction of a zygotic gene(s) that is required for the destruction 
of E2F1. 
The best possible experiment to test the requirement of E2F1 destruction will be to 
stabilize E2F1 protein during embryogenesis. If E2F1 destruction is required for the initial 
downregulation of E2F1-target genes, then the stabilization of E2F1 protein should result in 
the failure to downregulate E2F1-target genes. This experiment became technically possible 
when we discovered the mechanism of E2F1 destruction and successfully created a stabilized 
form of E2F1 (PIP mutant E2F1). However, the experiments employed in this thesis did not 
provide sufficient data to conclude about this hypothesis. We saw a normal initial 
downregulation of RnrS transcripts even with GFP-E2F1PIP overexpression although de-
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repression of RnrS at later stages was observed with the prd-Gal4-driven overexpression of 
GFP-E2F1WT or GFP-E2F1PIP (Figure 6A). This may imply that the initial downregulation of 
E2F1-target genes is not caused by the destruction of E2F1. Instead, other mechanisms may 
control this initial downregulation of E2F1-target genes. Although this is contradictory to our 
initial hypothesis stated in Chapter II, the later finding of E2F1-independent expression of 
RnrS (Chapter IV) indicates that E2F1-target genes can be regulated independently of E2F1 
during early embryogenesis. Alternatively, the normal initial downregulation of RnrS may be 
due to the low expression of GFP-E2F1s under the control of a weak UAS sequence (UASp), 
which we employed for the studies described here. Higher levels of transgene expression will 
be achieved by the use of UASt, which may provide sufficient levels of expression in the 
embryo to test whether E2F1 destruction is required for the initial downregulation of E2F1 
target genes. To confirm this, we are currently in the process of creating transgenic flies 
bearing UASt-GFP-E2f1s. However, we will not be able to test the hypothesis if 
overexpression with UASt induces too high expression, so that even the overexpression of 
E2F1WT prevents the initial downregulation of E2F1-target genes. 
  
E2F1-independent regulation of E2F1-target genes during Drosophila embryogenesis 
In addition to E2F1 destruction as an inhibitory mechanism of E2F1 activity, we 
discovered a possible E2F1-independent mechanism that positively regulates “E2F1-target 
genes”. As described in Chapter IV, we identified a genomic locus that is required for the 
early zygotic expression of RnrS. This locus does not contain the E2f1 gene, and E2F1 
protein expression was normal in the deletion mutant of the locus (Figure 4.4). Thus, the data 
suggests that E2F1 is not sufficient for the early zygotic expression of RnrS. However, it 
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should be noted that this does not exclude the possibility that E2F1 is “required” for the early 
zygotic expression of RnrS. Therefore, the discovery of the locus does not reject our 
hypothesis that the initial downregulation of zygotic E2F1-target genes is caused by the onset 
of E2F1 destruction. We hypothesize that the locus contains a gene(s) that positively 
regulates the early zygotic expression of RnrS. As candidate genes, we have identified 19 
genes in the locus. The discovery of the responsible gene will provide insight into the 
regulatory mechanism of E2F1-target genes during early embryogenesis. 
 
The mechanism of E2F1 destruction 
 In the work described in Chapter III, we established a FACS-based experimental 
system by which S phase-specific destruction of E2F1 can be robustly detected. Using this 
system, we discovered that the destruction of E2F1 is dependent on PIP box, PCNA, Cul4, 
and Cdt2. Since the destruction of Cdt1 is also dependent on PIP box, PCNA, Cul4, and Cdt2 
(Arias and Walter, 2006; Jin et al., 2006; Senga et al., 2006), we think that it is reasonable to 
conclude that Drosophila E2F1 and Cdt1 are degraded by a common mechanism.  
 Interestingly, E2F1 degradation appears dependent on its partner DP. E2F1 was 
stabilized when Dp was knocked down (Figure 3.4), and was destabilized when DP was co-
expressed (Figure 3.5). This led to the hypothesis that E2F1 degradation requires its binding 
to DP (and possibly to DNA). However, this hypothesis by itself cannot explain the fact that 
the N-terminal fragments of E2F1 (1-230, 93-184 and 139-230), which lacks both the DNA-
binding domain and DP-dimerization domain, can still be degraded during S phase (Figure 
3.1). As discussed in Chapter III, this may imply the existence of a signal sequence which 
resides in the 231-805 region and inhibits E2F1 destruction. The signal may be inactivated by 
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DP-binding, allowing the PIP box-dependent destruction of E2F1. This hypothesis can 
explain the fact that the N-terminal fragments are degraded during S phase in the absence of 
the DP-binding domain. In this hypothesis, the N-terminal fragments can be degraded since 
they do not contain the inhibitory signal, but full length E2F1 needs to be bound by DP in 
order to be degraded. It is interesting to test whether these N-terminal fragments are 
stabilized when a mutation is inserted to the PIP box. The hypothesis predicts that the N-
terminal fragments will be stabilized by a mutation in the PIP box. In addition, it will be 
informative to examine the stability of mutant E2F1s which lack the DNA-binding domain or 
the DP-dimerization domain. The DNA-binding domain will not be required for E2F1 
destruction if E2F1/DP dimerization by itself is sufficient to inactivate the putative inhibitory 
signal sequence. Alternatively, the DNA-binding domain will be required if DNA-binding, 
which is facilitated by E2F1/DP dimerization, is required for bypassing the inhibitory signal. 
Another hypothesis is that E2F1/DP induces transcription of genes involved in E2F1 
destruction such as Cdt2. In this case, Dp knockdown will stabilize all the E2F1 constructs 
including the N-terminal fragments. 
Since DDB1 is so far the only known adaptor protein that mediates the association of 
Cul4 and Cdt2 (Jin et al., 2006), it was surprising for us to find that Ddb1 knockdown did not 
result in the stabilization of E2F1 (Figure 3.4). One possibility is that the knockdown did not 
sufficiently reduce DDB1, even though successful DDB1 knockdown was confirmed by 
Western blot analysis (Figure 3.4). Alternatively, it is also possible that other DDB1-like 
proteins can compensate for the loss of DDB1. Interestingly, a recent report showed that a 
DDB1-like protein named SAP130 (Spliceosome-associated protein 130) interacts with 
Cul4a as well as Cul1 and 2 (Menon et al., 2008). SAP130 appears to be highly conserved in 
 121
Drosophila (CG13900, 75% homology to human SAP130 amino acid sequence). It is 
interesting to test whether CG13900 knockdown or Ddb1/CG13900 double knockdown 
stabilizes E2F1 during S phase in our S2 cell system. 
 
The Drosophila-specific evolution of E2F1 destruction mechanism 
 Drosophila E2F1 and mammalian E2F1 appear to be degraded via different 
ubiquitination pathways. Although PIP box is conserved in Cdt1 in mammals, flies, zebrafish, 
frog and worm (Arias and Walter, 2006; Senga et al., 2006), so far we did not find a putative 
PIP box in E2Fs of other species. This may indicate that the mechanism for E2F destruction 
has evolved in Drosophila differently from other organisms. Indeed, mammalian E2F1 is 
degraded in S/G2 (Marti et al., 1999) unlike Drosophila E2F1, which is degraded in early S 
phase (Asano et al., 1996; Reis and Edgar, 2004) (Figure 2.3). Consistent with this, the 
ubiquitination of mammalian E2F1 is linked to Cul1SKP2 (Marti et al., 1999), whereas our 
RNAi data indicated little contribution of Cul1 or SKP2 to the destruction of Drosophila 
E2F1 destruction (Figure 3.4). In addition, Ohta and Xiong showed that the in vitro 
ubiquitination of human E2F1 was enhanced by the addition of Cul1, 2, 3 and 5, but not by 
Cul4a (Ohta and Xiong, 2001), as opposed to our data that suggests the Cul4-dependent 
destruction of Drosophila E2F1. 
 
Apoptosis induced by E2F1 in mitotic cycles 
Activator E2Fs can act as positive regulators of apoptosis by inducing pro-apoptotic 
genes (Asano et al., 1996; Iaquinta and Lees, 2007; Moon et al., 2005; Muller et al., 2001). 
However, E2F-induced apoptosis is highly context-dependent, and little is known about the 
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mechanism that underlies this context-dependency (Hallstrom et al., 2008; Iaquinta and Lees, 
2007; Moon et al., 2006; Moon et al., 2005). The data presented here suggests that E2F1 
induces apoptosis when it is stabilized during S phase (Figure 3.8). Importantly, 
overexpression of GFP-E2F1WT did not induce apoptosis even though it is expressed at 
comparable levels to GFP-E2F1PIP outside S phase (Figure 3.8), reinforcing the idea that 
E2F1 overexpression outside S phase is not apoptosis-inducing. 
In general, E2F’s transcriptional activity reaches its peak in late G1, when activator 
E2Fs replace repressor E2Fs, and pRB dissociates from these activator E2Fs. This high E2F1 
activity in late G1 is thought to facilitate S phase entry and progress (Trimarchi and Lees, 
2002). We hypothesize that the activity of activator E2Fs is suppressed during S phase (and 
G2 in mammals) by the destruction of E2Fs via the ubiquitin-proteasome pathway in 
conjunction with the transcriptional repression of the E2f1 gene by E2F7/8 (mammals) or by 
CDK activity (Drosophila). Our results suggest that, when E2F activity remains high in S 
phase, cells may detect it and activate apoptotic pathways, otherwise the high E2F activity 
may cause overproliferation of cells, and possibly DNA re-replication through its induction 
of replication initiation factors such as Cdt1/dup. Alternatively, E2F1-induced re-replication 
may be the cause of apoptosis. If this is the case, wing disc cells expressing GFP-E2F1PIP 
may have died by apoptosis before any re-replication is detected (Figure 3.8).  
The existence of an S phase-specific, apoptosis-inducing sensor mechanism for E2F1 
activity is supported by the study by Asano et al. They showed that the heat shock-induced 
expression of Drosophila E2F1 in the eye disc induces apoptosis. However, the cells within 
or anterior to the morphogenetic furrow (a zone composed of cells in developmentally-
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regulated G1) did not undergo E2F1-induced S phase or subsequent apoptosis (Asano et al., 
1996).  
The question of how cells detect ectopic E2F1 activity during S phase will require 
future investigation to be answered. At least, a cell cycle-independent, constant threshold of 
E2F1 activity cannot be a sufficient explanation, because cells do not activate apoptotic 
pathways in late G1, when E2F1 activity peaks. 
Unlike in wing discs, no apoptosis induction was observed even when GFP-E2F1PIP 
was overexpressed in embryos (data not shown). As discussed above, this may reflect the fact 
that the UASp/Gal4 system we employed induces relatively low levels of transgene 
expression. However, our finding described in Chapter II indicates that E2F1 destruction 
does not occur even in S phase prior to cycle 15 (Figure 2.3). In spite of this, apoptosis is not 
seen in early embryogenesis. One possibility is that during early embryogenesis, cells possess 
a mechanism to escape from E2F1-induced apoptosis, so that they do not suffer from 
apoptosis even with high levels of E2F1 throughout the cell cycle. This escaping mechanism 
may be required to achieve very rapid cell cycles during early embryogenesis. After cells 
differentiate and obtain tight regulation by external signals, cells with inappropriately high 
levels of E2F1 during S phase may have to be eliminated in order to prevent 
overproliferation and/or DNA re-replication caused by elevated E2F1 activity. 
 
The significance of E2F1 destruction in endocycles 
Our data shown here suggest that endocycles are more susceptible to an increase in 
E2F1 level. In the embryonic gut, the synchronicity of endocycles was perturbed even with 
GFP-E2F1WT overexpression (Figure 3.7), making it impossible to compare the effects of 
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GFP-E2F1WT and GFP-E2F1PIP in this tissue. However, our collaborative work with Dr. 
Bruce Edgar has shown that the expression of GFP-E2F1PIP arrests the endocycles in the 
larval salivary gland, whereas the expression of GFP-E2F1WT does not (Figure 3.9). The 
onset of the cell cycle arrest caused by GFP-E2F1PIP is slow; scattered DNA replication was 
still observed at early larval stages (~72 hours after egg deposition), and the complete arrest 
was seen at later larval stages (~96 hours) (Kim et al. manuscript in preparation). This slow 
onset of the cell cycle arrest may explain the absence of cell cycle arrest in the embryonic gut 
overexpressing GFP-E2F1PIP. 
 
Concluding Remarks    
 The work presented in this thesis has advanced our understanding about E2F1 
regulation in the context of development. We showed evidence that the initial 
downregulation of E2F1-target genes during embryogenesis may be caused by the 
developmentally-regulated destruction of E2F1. Furthermore, we have identified the 
mechanism for E2F1 destruction using a FACS-based experimental system which was 
established for this study. It should be noted that this experimental system can be readily 
applied to investigation of other cell cycle-regulated proteins. Our data indicates that 
Drosophila E2F1 is degraded in a DNA replication-dependent manner. This finding revealed 
the existence of a robust negative feedback mechanism embedded in the central cell cycle 
regulatory machineries; E2F1 induces DNA replication, which in turn downregulates E2F1. 
This negative feedback is required for preventing apoptosis in a mitotic cycle (larval wing 
disc) and for the cell cycle progression of an endocycle (larval salivary gland). Additionally, 
E2F1PIP mutants created in this study will provide a useful tool for future experiment. 
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